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 The metabolism of feline follicles has been largely overlooked in reproductive 
science.  The primary objective of this study was to determine differences in metabolite 
profiles and glucose carbon fluxes in feline follicles of different developmental stages and 
subjected to different developmental environments.  Glycolytic flux, cholesterol (P 
<0.0001), pyruvic acid (P <0.0001), myo-Inositol (P =0.0003) and proline (P <0.0001) 
were higher in late versus early antral follicles.  Serine (P =0.0085), threonine (P <0.0001), 
and valine (P =0.0025) were significantly higher in early antral follicles cultured in vitro 
than those derived directly from feline ovaries; however, glucose carbon flux was not 
significantly different.  The current study suggests that early antral follicles undergo 
significant metabolic changes before progressing to the late antral stage.  While it appears 
that early antral follicles have diminished capacity to progress to the late antral stage in 
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Chapter 1:  Literature Review 
 
 
1.1.  Introduction 
 A deeper understanding of mammalian reproduction has become a major focus in 
research and in modern society.  While assisted reproductive efforts in humans, livestock, 
and endangered species are on the rise, challenges with assisted reproduction technologies 
(ARTs), in particular their overall low efficiency rates and paradoxically high number of 
multiple birth rates, continue to persist (Table 1).  According to the Society for Assisted 
Reproductive Technology (2011), in the United States only 46% of ART cycles in humans 
less than 35 years of age resulted in a pregnancy.  Of those pregnancies, nearly 40% 
resulted in twin, triplet, or higher order births.  Low efficiencies are due to a combination 
of problems that can be encountered during ART in humans as well as in livestock and 
wild species. For example, low gamete quality, cryopreservation of gametes, suboptimal 
culture techniques or media, low embryo quality, compromised recipients, amongst other 
factors all contribute.  Multiple births with ARTs are a result of widespread multiple 












Table 1.1:  Outcomes of ART cycles using fresh embryos derived from non-donor 
oocytes in 2003 and 2011 for different age groups in the United States (Society for 
Reproductive Technology, 2003 and 2011). 
 
 <35 35-37 38-40 41-42 >42 




36178 39721 18508 19930 17396 20130 7635 10277 3213 6033 
Pregnancy 
Rate  
(% of Cycles) 
43.3 46.2 36.4 38.5 27.1 29.3 18.6 19.5 9.8 9.1 
Live Birth 
Rate  
(% of Cycles) 
37.5 40.1 30.4 31.9 20.2 21.6 11.2 12.2 4.5 4.2 
Multiple 
Pregnancy 
Rate (% of 
Pregnancies) 
39.9 32 34 28 28.3 22.4 17.6 15.6 7.9 10.6 
 
 
Assessment of gamete quality for use in in vitro fertilization has remained limited, 
and fairly subjective, relying heavily on morphological markers. While the metabolism of 
gametes has been explored as a potential benchmark for quality in the past, a thorough 
understanding through direct measure has yet to be realized.  Attaining a better 
understanding of the metabolism of gametes and embryos could lead to an improvement in 
outcomes of ARTs in mammalian species, achieved through better selection of oocytes and 
sperm for use in ART and through improved culture procedures.  Using the domestic cat 
(felis catus) as the animal model, the aim of this research was to define developmental 
shifts in follicle metabolism by employing state-of-the-art metabolomic and 13C-fluxomic 
technologies. Ultimately, this basic information can be used to identify metabolic markers 
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of “healthy” follicles.  Specific aims were to refine current protocols to optimize extraction 
of metabolites from follicles, to facilitate elucidation of the metabolic profile and pathway 
fluxes (13C-fluxome) of follicles at different developmental stages and under differing 
environmental conditions.  Future studies could use this metabolic information to refine 
culture protocols (e.g., media composition) to support the essential metabolic requirements 
of developing follicles (and oocytes).  Overall, the procedures utilized in and results 
obtained from this research can be employed in practice to improve current ART 
approaches for successful culture and selection of viable gametes. 
 
1.2.  Overview of Reproduction and the Reproductive Cycle in felis catus 
 Female domestic cats, queens, become sexually mature between four and twelve 
months of age.  Factors affecting the onset of puberty include the breed of cat, body weight 
of the animal, as well as time of year (Jemmett and Evans, 1977; Lofstedt, 1982).  They 
are seasonally polyestrous animals who have several estrous cycles during spring and 
summer, when the hours of daylight per day increases (long day breeders).  Cats are 
classified as induced or reflex ovulators, typically requiring the physical stimulation of a 
tom’s penile barbs during coitus to induce ovulation (Malandain et al., 2011; Goodrowe et 
al., 1989).  However, it has been shown that external, environmental cues can also induce 
ovulation.  Visual cues, such as the presence of other cats, and pheromonal cues have 
triggered ovulation in the domestic cat and in some wild felid species (Lawler et al., 1993; 
Gudermuth et al., 1997; Feldman and Nelson, 1996). 
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 The estrous cycle of queens consists of several phases including the anovulatory 
follicular phases (proestrus and estrus), metestrus and diestrus if ovulation occurs, or 
interestrus if ovulation does not occur, and anestrus. 
 
     1.2.1. The Follicular Phase:  Proestrus & Estrus 
 The proestrus period of the queen’s estrous cycle is marked by affectionate 
behaviors that can also be observed during estrus, such as rubbing the head and neck on 
surrounding objects.  In contrast to estrus, proestrus is not accompanied by receptiveness 
to breeding with toms (Feldman, 1996).  This period is short in domestic cats and typically 
lasts only one or two days.  Progesterone levels drop drastically during this period, allowing 
for an increase in production of gonadotropin releasing hormone (GnRH) from the 
hypothalamus.  GnRH release is affected by a number of factors in addition to 
progesterone, including indirect affect by leptin, stimulation of release by kisspeptin, and 
in response to changes in photoperiod (d’Anglemont de Tassigny and Colledge, 2010; 
Quennell et al., 2005; Hidahl et al., 2013).  GnRH causes increased release of follicle 
stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior lobe of the 
pituitary.  The increase in FSH stimulates the onset of follicular recruitment and allows for 
a continuing wave of follicle development from the activated reserves in the ovary.  As the 
early antral follicles begin to enlarge and develop, LH acts on thecal cells to induce 
androgen production.  The increase in androgens stimulates granulosa cell proliferation, 
causing an accompanying rise in estradiol levels in the blood as androgens are released.  
The rise in estradiol sparks behavioral estrus in the female, and begins vaginal cornification 
(Feldman, 1996; Shille et al., 1979). 
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 As estrus approaches, many of the follicles which had been recruited become 
atretic, while few are selected to continue development.  As opposed to monotocous 
species, where one of the selected follicles becomes dominant, in cats three to seven 
selected follicles go on to become dominant, while the others become atretic (Feldman, 
1996).   
 During estrus, which lasts approximately seven days, affectionate behaviors persist.  
Rubbing, vocalizing, presenting the hindquarters, expressing lordosis, and travelling 
rhythmically with the hind legs are all physical and behavioral signs of estrus which 
culminate in receptivity to breeding (Tsutsui and Stabenfeldt, 1993).  Peak estradiol 
secretion is reached during the estrus phase, allowing for a surge in LH release (Feldman, 
1996).  The physical stimulus during mating (intensity and frequency) determines the level 
of LH release, and if adequate, results in the ovulation of oocytes from the preovulatory 
(dominant) follicles. 
  
     1.2.2.  The Luteal Phase:  Metestrus and Diestrus 
 If the queen is mated during estrus and ovulation occurs, she will enter a period of 
metestrus at which time the corpus luteum develops and progesterone secretion increases 
(Shille et al, 1979).  During diestrus, functional corpora lutea (CL) are present, and 
progesterone reaches peak serum concentrations.  If pregnancy results, progesterone levels 
remain high, and diestrus persists for approximately 60 days.  If pregnancy does not result, 
the queen will experience a period of psuedopregnancy, which lasts about 40 days (Bristol-




     1.2.3.  Interestrus 
 If the queen does not ovulate during estrus, either due to a lack of mating or failure 
to ovulate during mating, she enters a period of interestrus, which lasts about seven days.  
At the completion of this period, the follicular phase of the estrous cycle begins again 
(Lofstedt, 1982). 
 
1.2.4.  Anestrus 
 During the periods of the year in which the queen is not actively cycling (winter 
and fall), the queen is in a period of anestrus.  This period is marked by low concentrations 
of both estradiol and progesterone in the blood (Feldman, 1996). 
 
1.3.  Embryonic Development of the Ovary and Primordial Follicles 
During embryonic development, mitotically active primordial germ cells migrate 
from the epithelium of the yolk sac to the genital ridge, drawn by chemotactic signals (Aerts 
and Bols, 2010).  This invasion induces the formation of the gonadal cords, which further 
differentiate into the rete ovarii (Byskov, 1975).  Mitotically active germ cells, upon arrival 
to the gonad and embedment, are termed oogonia (Aerts and Bols, 2010).   
The oogonia, now surrounded by somatic cells (precursors of granulosa cells), 
continue a series of synchronous, incomplete mitotic divisions resulting in “cysts” joined 
by cytoplasmic bridges by which mitochondria and other organelles can be exchanged 
(Pepling and Spradling, 1998).  Following several synchronized mitotic divisions, oogonia 
enter their first meiotic division.  During this division, the cytoplasmic bridges degrade, 
and the somatic cells surrounding the cyst or “syncytium” begin to encapsulate individual 
oocytes.  These primary oocytes enter a period of developmental arrest at the diplotene 
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stage of Prophase I (Cooper, 2000).  The flattened somatic cells (granulosa cells) complete 
their encapsulation of individual primary oocytes and are separated from the ovarian 
stroma by a basal lamina which is deposited on their outer surface, completing the 
formation of the primordial follicles (Merchant-Larios and Chimal-Monroy, 1989).   
This process of primary oocyte formation occurs at varying time points during 
embryonic development, depending on the species.  In the domestic cat, the process begins 
at approximately 40-50 days of fetal development and reaches completion at 8 days after 
birth (Bristol-Gould and Woodruff, 2006).  In cattle, fully formed primordial follicles can 
be found at 90 days of gestation (Aerts and Bols, 2010).  It has long been accepted that 
female mammals are endowed with a finite reserve of these primary oocytes at the time of 
birth; however, the presence of germ stem cells in mammals after birth into adulthood is 
still hotly contested and under investigation (Fortune, 2003).  It has been shown that in 
mice, germ stem cells persist after birth, but currently it is unknown as to whether other 
mammals, in particular the domestic cat, are born with or without germ stem cells (Johnson 
et al., 2004). 
At the shift from mitosis to meiosis, mammals have their highest number of germ 
cells, most of which will go through apoptosis prior to the animal’s birth.  The perinatal 
reduction in germ cell numbers has previously been associated with the breakdown of cysts 
and the degradation of their cytoplasmic bridges (Ratts et al., 1995).  The total number of 
primordial follicles present at this transition, and the degree of reduction, appears to be 
species dependent.  In humans, a maximum of roughly seven million primordial germ cells 
are present at this transition, with only about 28.6% surviving until birth (Pepling and 
Spradling, 2001).  In cows, the reduction is even more drastic, with about 2.1 million 
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primordial germ cells existing at the transition, dropping by about 94% to roughly 130,000 
at birth (Erickson, 1966a,b).   
The ovaries at the time of birth are complex organs containing several differentiated 
cell types, all of which work together to achieve healthy organ function (Bristol-Gould and 
Woodruff, 2006).    The gross anatomy of the ovary consists of an outer cortex surrounding 
a central medulla.  The cortex is encapsulated within collagenous connective tissue, the 
tunica albuginea, which has a single layer of cuboidal epithelial cells on its perimeter.  
Lymphatic and cardiovascular vessels, as well as nerve fibers, reside within the medullary 
region of the ovary.  The cortical region houses the primordial and primary follicles, which 
are tightly embedded in elastin fibers, fibroblasts, and collagen (Aerts and Bols, 2010). 
 
1.4.  Follicular Classification and Cell Types in Domestic Cats 
The mammalian follicle consists of several differentiating cell types, and holds at 
its core a single oocyte encapsulated within granulosa cells.  The follicle is fundamentally 
responsible for facilitating the development of a viable oocyte, as well as producing 
hormones and steroids essential to normal female reproduction.  Follicle classifications 
have been established to describe developmental stages in order to understand follicle 
progression and to allow for systematic study.  These classifications ultimately describe 
the follicles based on cell types present and their morphology, and they also indicate the 
approximate size of the follicle.  The most common terminology used to denote 
mammalian follicle stages describes four major classes:  primordial, primary, secondary, 
and tertiary follicles.  More specific terminology and subclasses exist and are species-




1.4.1.  Primordial Follicles 
Primordial follicles are the earliest developmental stage, and consist of a quiescent 
oocyte, arrested in Prophase I, surrounded by a singular layer of granulosa cells.  In cats, 
there are three subclasses of primordial follicles:  B Class, B/C Class, and C Class (also 
called Primary Follicles which will be discussed below).  B Class primordial follicles 
consist of an oocyte which is roughly 20-30 µm in diameter, surrounded by a single layer 
of squamous granulosa cells.  Anywhere from one to eight granulosa cells can be present 
at this stage and directly surrounds the oocyte.  B/C primordial follicles, or transitory 
primordial follicles, have entered the first growth phase and contain both squamous and 
cuboidal granulosa cells in a singular layer surrounding the oocyte (Bristol-Gould and 
Woodruff, 2006; Gougeon and Chainy, 1987; Meredith et al., 2000). 
 
1.4.2.  Primary Follicles 
 Primary follicles, also called Class C Primordial follicles, continue to grow and 
develop beyond their predecessor primordial follicles.  Their growth is accompanied by an 
increase in size of the enclosed oocyte, which now ranges from 30 to 50 µm in diameter. 
These follicles are distinguished by a single layer of uniformly cuboidal granulosa cells 
surrounding the oocyte.  This class of follicle is completely isolated from the ovarian 






1.4.3.  Secondary Follicles 
 Secondary follicles have entered a secondary growth phase, and are identified by 
the presence of two or more layers of cuboidal granulosa cells surrounding the oocyte.  
Their size varies depending upon the number of layers of granulosa cells present, but 
typically ranges from 100 to 400 µm in diameter.  The multiple layers of granulosa cells 
surround the oocyte, which at this point is between 40 and 75 µm in diameter.  In addition 
to granulosa cell layers, these follicles also contain a theca cell layer which is distributed 
opposite the basement membrane to the granulosa cells (Bristol-Gould and Woodruff, 
2006).  At this point in follicular development the zona pellucida has already begun 











1.4.4.  Tertiary Follicles 
 Tertiary follicles are distinguishable from other developmental stages by the 
formation of fluid-filled cavities.  Early antral formation begins as several isolated pools 
developing within the granulosa layers, which eventually increase in size and unite into a 
single antrum (Smitz and Cortvrindt, 2002).  Additional distinguishing characteristics of 
early antral follicles include the presence of two or three layers of thecal cells bordering 
the basement membrane.  Late antral follicles, however, contain many layers of thecal cells, 
divided into two categories, the interna and externa, distinct mural and cumulus granulosa 
cell layers, as well as a single, large antrum (Figure 1.2).  These late antral follicles are 
aptly located at the perimeter of the ovarian cortex, poised for ovulation (Bristol-Gould 
and Woodruff, 2006).  These follicles vary greatly in size depending on the stage of 
development of the antrum.  Smaller, early antral follicles can be between 300 and 1000 
µm in diameter, surrounding an oocyte 75 to 90 µm in diameter, while late antral follicles 
or Graffian follicles can range from 2000 to 3000 µm in diameter, housing an oocyte 85 to 
100 µm in diameter.   
 
Figure 1.2:  Morphology of a Graafian Follicle (Schematic).  Adapted from Aerts 
and Bols, 2010. 
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1.5.  Folliculogenesis and Oocyte Growth and Development 
1.5.1.  General Patterns of Folliculogenesis and Oocyte Growth 
At birth, most mammals are born with a finite ovarian reserve of primordial 
follicles.  In many livestock species and in humans, upon attainment of sexual maturity, 
groups of quiescent primordial follicles begin to mature in waves, during a highly 
coordinated process known as folliculogenesis.  While it is known that a vast number of 
these dormant primordial follicles are activated to begin growing and maturing, the 
mechanisms by which this occurs, and by which follicles are selected for dominance, are 
largely unknown and still being explored (Jewgenow and Goritz, 1995; Aerts and Bols, 
2010).  Conversely, the pattern of follicle development in cats is not as well understood, 
and is complicated by the fact that they are induced ovulators.   
In cattle, follicles are initiated to develop in two or three waves.  The first wave is 
initiated on the day of ovulation of the previous cycle, the second 9-10 days later (two 
wave) or 8-9 days later (in cows with three waves), and on day 15-16 (if three waves).  In 
cattle, only the dominant follicle of the second wave (if two waves develop) or the third 
wave (if three waves are present) is ovulated. 
The ovarian reserve of primordial follicles is dormant prior to puberty, and is 
marked by relatively quiescent transcription and translation.  The oocytes enveloped in 
these primordial follicles are arrested at the diplotene stage of Prophase I.  The activation 
of folliculogenesis is gonadotropin independent, that is, primordial follicles develop to the 
primary follicle stage free from the control of FSH and LH.  Evidence suggests that this 
initial stage of activation requires KIT ligand (KL) from granulosa cells to bind to KIT 
tyrosine kinase receptors on the oocyte.  This prompts oocyte survival and growth, which 
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in turn stimulates granulosa cell proliferation (Parrott and Skinner, 1999; Kidder and 
Vanderhyden, 2010).  At this transition, follicles are considered to be committed to 
continued development; however, atresia is the fate of most of these follicles rather than 
survival. 
These primary follicles continue to develop through to the late preantral or early 
antral stage independent of the control of FSH.  In cattle, many growth factors are involved 
during this processs (Lucy, 2007).  Bone morphogenic proteins (BMPs) and receptors, as 
well as epidermal growth factors (EGFs) are among the members of the transforming 
growth factor-β superfamily (TGF-β) which contribute (McNatty et al., 2005; Knight and 
Glister, 2006).  Insulin-like growth factors also contribute during this period of 
development (Lucy, 2000).  Throughout this time course, the oocyte begins to grow and 
accumulate mass, which is only achievable because it does not divide.  Once the early 
antral phase is achieved by the maturing follicles, the recruitment process occurs.  Due to 
increasing levels of circulating FSH, which acts as a “survival factor” for these follicles, 
several are recruited to continue development, escaping the atretic fate of the other follicles 
in the cohort. 
Of the recruited early antral follicles, one or more are selected to continue 
development, depending on the ovulatory pattern of the species, while the others become 
atretic.  It has been suggested that during this process, growing follicles secrete inhibin and 
estradiol, decreasing FSH release, and aiding in the selection process (Aerts and Bols, 
2010).  Throughout this process of selection, all selected antral follicles retain their ability 
to become dominant follicle(s). 
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The number of follicles which attain dominance and survive in each wave is 
dependent upon the species (Kidder and Vanderhyden, 2010).  In monovular species, such 
as bovids and equids, generally only a single dominant follicle will be present; conversely, 
in polyovular species, such as felids and canids, multiple dominant follicles will be present.  
When the largest follicles of the cohort attains their maximal size, a differentiation occurs 
between those follicles which achieve dominance, and the subordinate follicles.  All 
selected follicles had the capacity to become the dominant follicle(s); however, post-
differentiation, only those that have achieved dominance have the potential to ovulate, 
while the subordinates simply regress in size.  Vascularization of the thecal layer is of 
utmost importance during the process of achieving dominance.  Factors which promote 
vascularization in cattle include vascular endothelial growth factor, angioproteins, and 
basic fibroblast growth factor (Tamanini and DeAmbrogi, 2004; Berisha and Schams, 
2005).  Of those follicles which obtain dominance, only those follicles belonging to the 
second wave, in a cow with a two-wave pattern, or those belonging to the third wave, in 
the case of a three-wave pattern, are actually ovulated, while the dominant follicles of the 
first and second (in the case of a three wave pattern) become atretic. 
Due to the wave-like nature of activation, recruitment, selection, and dominance, 
at any point in time there are follicles at almost every stage of development in the ovary 
(Bristol-Gould and Woodruff, 2006). 
 
1.5.2.  Dominance in the Domestic Cat 
Malandain et al. (2011) found that on the first day of estrus in domestic cats, 
roughly four to five follicles were healthy dominant follicles, with a range of two to seven 
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per female cat.  Their mean diameter was 2.3±0.01 mm on the initial day of estrus, and 
they continued to grow 0.2 (±0.04) mm per day, with at least one follicle in the cohort 
measuring 3.0 mm by the end of behavioral estrus.  The maximum size of the dominant, 
preovulatory follicles was 3.5 (±0.04) mm, reached approximately 3.8 days after the onset 
of estrus.  If ovulation was not achieved, the dominant follicles became atretic and 
decreased in size, largely due to the collapse of the formed antrum.  It is important to note, 
however, that during estrus, the growth of dominant follicles is not wholly synchronous.  
The ultimate size of the dominant follicles, as well as number of days from the onset of 
estrus it takes them to reach maximum diameter, varies between follicles and cohorts.  The 
size can easily be monitored using transabdominal ultrasonography techniques, which are 
a more reliable indicator of follicular size than behavioral observation, vaginal smears, or 
estradiol assays from serum (Malandain, 2011). 
 
1.5.3.  Additional Proposed Coordination Strategies 
Coordination of this highly complicated process is extremely dependent on cell to 
cell communication within the follicle – including communication between somatic cells 
and between somatic cells and the oocyte.  While paracrine factors and direct 
communication via gap junctions are well documented, many methods of communication 
have been proposed. 
In addition to being involved in the initial activation of primordial follicle growth, 
KL and the receptor c-kit are also involved in the coordination of thecal cell growth, steroid 
(androstenedione) production, and differentiation in bovine follicles.  Granulosa cells 
produce kit-ligand in increasing amounts as follicles increase in size; however, c-kit 
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receptor abundance does not increase in the same size-dependent manner (determined by 
total RNA measured via reverse transcription PCR).  Still, it suggests that KL/c-kit 
interactions play an increasing role in supporting growth and steroid production for 
dominant follicles (Parrott and Skinner, 1995). 
Fibroblast growth factors (FGFs) have been associated with the coordination of 
folliculogenic events as well.  In several species, including the rat and cow, FGF-2 from 
the oocyte has been implicated in the stimulation of primordial follicle growth, in their 
transition to primary follicles, and in recruitment (van den Hurk and Zhao, 2005).  A similar 
pattern is observed in canids.  For dogs not in a period of anestrus, FGF-2 is localized in 
the oocyte and granulosa cells of primordial, primary, and secondary follicles.  FGF-7 
localization was dependent upon follicular stage:  being found in granulosa cells in primary 
follicles, granulosa and theca cells in secondary follicles, and only in the thecal cells of 
antral follicles during the proestrus and estrus reproductive phases (Songsasen et al., 2009).   
In mares, membrane enclosed vesicles, “microvesicles”, and exosomes have been 
proposed as a mode of communication within the follicle.  Microvesicles and exosomes 
located in the follicular fluid of equine antral follicles are taken up by proximal granulosa 
cells.  The exosomes contain known exosomal proteins, while both the microvesicles and 
the exosomes contain micro-RNA (miRNA).  The miRNAs found within these structures 
were also isolated from surrounding mural and cumulus cells, suggesting the exomsomes 
and microvesicles were taken up from the follicular fluid.  Interestingly, the amount and 
types of miRNA isolated varied between in mares of different ages, which could suggest a 




1.6.  Historical Understanding of Follicle and Oocyte Metabolism 
The process of follicular growth and development is a very energy-dependent 
process; however, the metabolic processes by which follicles and oocytes obtain this 
energy are not very well understood (Sutton et al., 2003).  Metabolic studies have 
historically focused on a limited number of exogenous substrates thought to be required by 
oocytes and follicles, and are hindered by the fact that substrate utilization is generally not 
measured directly, but rather through analysis of spent media (Biggers et al., 1967; 
Brinster, 1971; Rieger and Loskutoff, 1994; Songsasen et al., 2007; Spindler et al., 2000; 
Gardner et al., 2001; Sakkas et al., 2008).   
      
     1.6.1.  Follicle and Cumulus-Oocyte Complex Metabolism 
Commercially available kits and photometric assays have been employed to study 
relationships between the concentrations of metabolites found in follicular fluid to their 
concentrations in serum.  Leroy et al. (2004b) examined the levels of glucose, urea, total 
protein, non-esterified fatty acids, triglycerides, β-hydroxybutyrate (β-OHB), and total 
cholesterol in the serum and follicular fluid of high-producing dairy cows.  It was found 
that in follicular fluid as compared to serum, glucose levels were much higher.  Conversely, 
with the exception of urea and β-hydroxybutyrate, all other compounds were found at 
significantly lower concentrations in follicular fluid.  A poignant finding was that 
metabolite concentration changes in follicular fluid mirrored the changes in serum 
throughout the study, cementing the importance of the follicular environment, whether in 




       1.6.1.1.  Glucose Metabolism 
 The pattern of glucose uptake and presence in follicular fluid is consistent across 
species:  as follicle size increases, glucose concentrations in the fluid increase.  
Commercially available clinical analyzer kits have been used to determine the levels of 
glucose in follicular fluid of buffalo, heifer, and sheep follicles.  In buffalo, follicular fluid 
concentrations of glucose in small follicles (<3mm) was 2.04 (± 0.25) mM, whereas 
significantly higher concentrations (2.74 ± 0.21 mM) were observed in large follicles 
(>8mm).  This trend was mirrored in sheep, which exhibited a glucose concentration of 
1.18 (± 0.13) mM in small follicles (<2mm) and 1.64 mM in large follicles (>4mm) (Nandi 
et al., 2008).  In dairy cows, concentrations of glucose are also higher (3.75 ± 0.18 mM) in 
larger follicles compared to smaller follicles (2.01 ± 0.10 mM) (Leroy et al., 2004a).  In 
heifers, growing follicles (<8.5mm) exhibited glucose concentrations of 2.37 (± 0.95) mM 
in follicular fluid, while concentrations in preovulatory follicles (>8.5mm) were much 
higher (4.04 ± 0.33 mM) (Nishimoto et al., 2009).   
This finding is supported through the monitoring of incorporation of fluorescent 
glucose analogs from culture media.  It has been shown that granulosa cells facilitate 
glucose transport into the follicle, but limited quantities are delivered to the oocyte, due to 
the oocyte’s reduced capacity for glucose uptake (Sutton-McDowall et al., 2010).  As 
follicle size increases, especially through early stages of development, the number of 
granulosa cells greatly increase, which allows for higher levels of glucose to be taken up 
from the surrounding environment.   
The glycolytic pathway in the cumulus-oocyte complex (COC) – particularly in the 
cumulus cells – is a highly active pathway.  In the granulosa cells, glycolytic activity 
19 
 
accounts for the majority of glucose utilization for ATP production as well as for the 
synthesis of substrates used by the oocyte.   Due to the limited ability of oocytes to uptake 
glucose, granulosa cells preferentially metabolize glucose to pyruvate and lactate which 
the oocyte metabolizes for energy.  It has been observed that glucose uptake increases 
during in vitro oocyte maturation; however, glycolytic activity (approximated by the 
disappearance of glucose, and appearance of lactate in spent media) does not reflect that 
increase (Sutton-McDowall et al., 2010).   
While the pentose phosphate pathway (PPP) only constitutes a small proportion of 
glucose metabolized by granulosa cells of the COC, it has been suggested that the oocyte 
has a much higher capacity for PPP activity (Sutton-McDowall et al., 2010). 
  
       1.6.1.2.  Lactate Metabolism 
Follicular fluid concentrations of lactate appear to be inversely related to the 
concentration of glucose.  Follicular fluid concentrations of lactate in small follicles from 
buffalo were 10.18 (± 1.04) mM, decreasing to 5.16 (± 1.02) mM in large follicles.  In 
sheep, lactate concentrations of 14.12 (± 1.42) mM were observed in small follicles while 
6.47 (± 0.84) mM was observed in larger follicles (Nandi et al., 2008).  In dairy cows, 
lactate in follicular fluid is also lower in large (5.6 ± 0.37 mM) follicles compared to 
smaller follicles where concentrations were greater than two fold higher (14.4 ± 0.35 mM) 
(Leroy et al., 2004a).  By contrast, in heifers, lactate concentrations in follicular fluid of 
growing follicles (5.43 ± 0.82 mM) is higher than in preovulatory follicles (3.37 ± 1.16 




       1.6.1.3.  Pyruvate Metabolism 
Pyruvate concentrations do not appear to be dependent upon follicular 
development.  Follicular fluid concentrations remain relatively constant across the range 
follicular sizes in buffalo and sheep, varying from 0.01 (± 0.01) mM to 0.04 (± 0.01) mM 
and from 0.001 (± 0.01) mM to 0.003 (± 0.00) mM in buffalo and sheep, respectively 
(Nandi et al., 2008). 
 
       1.6.1.4.  Amino Acid Metabolism 
Recently, Guérin et al. (2012) reported one of the most comprehensive studies in 
cats, and the concentrations of amino acids in fallopian tube and follicular fluid aspirations.  
These authors found that the most abundant amino acids in feline follicular fluid were 
alanine (359 µM), glutamine (351 µM), and taurine (258 µM); however, the most abundant 
amino acids in tubal fluid were glycine (840 µM), glutamate (808 µM), and taurine (596 
µM).  Whole fluid samples were analyzed by high-performance liquid chromatography 
(HPLC). 
 
       1.6.1.5.  Fatty Acids, Triglycerides, and Lipids 
 Fatty acid and lipid profiles vary among species and developmental stages of 
mammalian follicles.  In dairy cows, concentrations of triglycerides significantly differed 
between follicle sizes, with the highest levels found in small follicles (21.8 ± 0.60 mg/dl) 
and the lowest in larger follicles (12.4 ± 0.45 mg/dl).  Non-esterified fatty acids have also 
been measured in dairy cow follicles; however, concentrations were not observed to differ 
with follicle size, ranging from 0.47 (± 0.04) mM to 0.44 (± 0.08) mM (Leroy et al., 2004a).  
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In studies considering murine, bovine, and porcine COCs, murine COCs had the lowest 
lipid concentrations, while porcine COCs exhibited the highest concentrations.  Of all fatty 
acids, palmitic and oleic acids were the most abundant in immature bovine and porcine 
COCs.  Paczkowski et al. (2013) evaluated the role of fatty acid beta-oxidation (FAO) in 
in vitro COC metabolism and viability when in the presence or absence of the FAO 
inhibitor etomoxir (carnitine palmitoyltransferase 1 inhibitor).  Oocyte nuclear maturation 
was inhibited in all three species when FAO was inhibited, demonstrating that FAO is 
essential for oocyte nuclear maturation.  In mice and cows, when etomoxir was added at 
concentrations which did not wholly prevent oocyte nuclear maturation, glucose 
consumption increased, suggesting that when FAO is compromised, glucose metabolism 
increases to fulfill the metabolic demands of the COC. 
 
       1.6.1.6.  Additional Metabolic Markers 
 Determination of fractional oxygen concentration in aspirated follicular fluid from 
preovulatory follicles has been performed using fluorometric fiber-optic oxygen sensors.  
In Holstein cows, typical oxygen concentrations in the follicular fluid of preovulatory 
follicles is 6.9%.  While it is known that heat stress can negatively affect fertility in dairy 
cows, oxygen consumption is not significantly affected (concentrations increased to 7.3%) 
(de Castro e Paula et al., 2007). 
 Follicular steroid synthesis has been evaluated by determining the concentration of 
estradiol-17β and progesterone in the preovulatory follicular fluid of Holsetin cows by 
radioimmunoassay.  In cows with a preovulatory follicle, follicular fluid concentrations of 
estradiol-17β were 1,264.5 (± 84.3) ng/mL while those of progesterone were 142.6 (± 12.7) 
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ng/mL.  While heat stress is known to decrease fertility in cows, these authors did not 
observe differences in steroid concentrations in preovulatory follicular fluid from cows 
exposed to thermo-neutral conditions compared to those under heat stress conditions (de 
Castro e Paula et al., 2007). 
Several commercially available kits and photometric assays have been employed 
in the study of bovine follicular fluid and serum.  Leroy et al. (2004a) examined the levels 
of urea, total protein, β-OHB, total cholesterol, and the electrolytes chloride, potassium, 
and sodium in follicular fluid of high-producing dairy cows.  In large follicles, 
concentrations of β-OHB and total cholesterol were significantly higher, while those of 
urea, chloride and potassium were significantly lower compared to smaller follicles (Leroy 
et al., 2004a). 
 
     1.6.2.  Oocyte Metabolism 
 Radioactive isotope tracers of pyruvate, glucose, and glutamine have been used as 
probes to interrogate the metabolism of oocytes derived from cattle and dogs (Steeves and 
Gardner, 1999; Songsasen, 2012).  Oocytes were cultured in maturation media, then 
transferred to a “hanging drop” on the lid of an Eppendorf tube containing a sodium 
bicarbonate trap to determine oocyte oxidation of the above substrates.  For oocytes from 
adult cows, peak pyruvate metabolism was reached at 12 hrs of maturation, peak glutamine 
metabolism was achieved at 24 hrs (increasing linearly throughout maturation), while 
glucose metabolism increased throughout the 24 hr maturation period.  A similar temporal 
pattern of substrate oxidation was also observed for bovine oocytes collected from 
prepubertal animals (Steeves and Gardner, 1999).  Similarly, in dogs, oocytes achieving 
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nuclear maturation by 48 hrs had higher glycolytic rates than oocytes which arrested.  In 
addition, metaphase II stage oocytes from larger follicles had higher rates of glutamine 
oxidation than same stage oocytes derived from smaller follicles (Songsasen, 2012).  
 
1.7. Assisted Reproductive Technologies 
In vitro culture (IVC) of gametes, follicles, and embryos, in vitro fertilization (IVF) 
of oocytes with sperm followed by embryo transfer (ET) to recipients, and artificial 
insemination (AI) of females are all ARTs that are currently employed in humans, 
livestock, and wild species (Yamamoto et al., 1999).  
 
     1.7.1.  Techniques Available 
 To date, the only species that the entire processes of folliculogenesis (from 
primordial to late antral), oocyte maturation, fertilization and subsequent ET have been 
successfully achieved in vitro is the mouse.  The success of this process is dependent upon 
many endocrine and paracrine factors, communication between the oocyte and follicular 
cells, as well as the culture media and conditions.   
Preantral follicles can be isolated from ovaries enzymatically or mechanically.  
While enzymatic digestion of the ovarian cortex allows for greater numbers of recovered 
preantral follicles, their structural integrity is compromised.  Mechanical isolation allows 
for lower recovery, but better preserves the follicle’s three dimensional structure (Eppig 
and Schroeder, 1989; Demeestere et al., 2002).  Isolated follicles can be cultured under 
varying conditions, but typically, they are cultured under non-adherent conditions, attached 
to the culture dish, embedded within a collagen matrix, or cultured on collagen-
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impregnated membranes (Torrance et al., 1989; Eppig et al., 1996; Cortvrindt et al., 1996, 
Nayudu and Osborn, 1992).   
To increase survival, it is critical that the three-dimensional structure of isolated 
follicles (whether preantral stage or later) is preserved during whole follicle incubation; 
however, the method of preservation presents a challenge – how to encase the follicle, yet 
allow for adequate substrate availability.  Several methods have been employed to achieve 
these two goals, including follicle encapsulation in alginate hydrogel.  Alginate hydrogels 
(0.5%) have been used successfully in several species for in vitro follicle culture, including 
human follicles.  However, culture in alginate hydrogel can present unique challenges.  For 
example, a high concentration of alginate (1-1.5% w/v) leads to a selective reduction in 
steroidogenesis and prevents follicular growth due to the encapsulation restricting the 
follicle during expansion. This issue tends to arise when culture is carried out for long 
periods of time (West et al., 2007; Telfer and McLaughlin, 2011).  Shikanov et al. (2011) 
proposed a method using fibrin-alginate interpenetrating networks.  These provide the 
structural support of alginate hydrogels which the follicle requires, but also allows for 
normal expansion of the follicle as the fibrin-matrix degrades over time as a result of 
protease secretions from the follicle. 
   During in vitro culture of murine follicles, low concentrations of LH increase the 
follicle’s capacity to form an antral cavity, as well as increasing oocyte meiotic maturation 
(Cortvindt et al., 1998).  FSH is required at levels of at least 10 mUI/mL (up to 100 
mUI/mL) for successful intact preantral follicle culture.  Survival rates in the absence of 
FSH are only 10-17% (Mitchell et al., 2002; Cortvindt et al., 1997; Nayadu and Osborn, 
1992).  FSH does not appear to be required for successful in vitro culture of COCs because 
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oocyte maturation can be achieved in the absence of FSH (Eppig and Shroeder, 1989).  
Fetal calf serum or hypogonadal mouse serum are typically added (5%) to intact follicle 
culture systems as a source of protein (amino acids) as well as to reduce the incidence of 
apoptosis (Mitchell et al., 2002; Demeestere et al., 2005).  Ascorbic acid can also be added 
to serum-free culture media of intact follicles, or to culture media of COCs, to reduce the 
incidence of apoptosis (Eppig et al., 2000).   
Certain paracrine factors exhibit inhibitory effects on follicular growth in vitro.  
Interleukin-6 and tumor necrosis factor-α induce apoptosis, while administration of leptin 
suppresses follicular growth (Chun and Hsueh, 1998; Kikuchi et al., 2001).  Contradictory 
effects of anti-müllerian hormone on in vitro culture systems have been observed 
(Durlinger et al., 2001; McGee et al., 2001).  Initial follicular recruitment is partially 
dependent upon growth differentiation factor-9 and BMP-15, both expressed by the oocyte, 
which stimulate granulosa cell proliferation (Hayashi et al., 1999; Shimasaki et al., 2004).  
In addition, interaction between c-kit (encoded in the oocyte) and KL (encoded in the 
granulosa cells) are responsible for initiation of follicular growth.  This interaction has 
continued effects throughout antral follicle growth and differentiation (see review by 
Demeestere et al., 2005).  Addition of KL increases granulosa cell proliferation and oocyte 
maturation during in vitro culture of preantral follicles (Reynaud et al., 2000).  Addition of 
EGF at physiologic concentrations to in vitro culture media also increases the number of 
follicles that reach the antral stage (McGee et al., 1997). 
 Fouladi-Nashta and Campbell (2006) have demonstrated that insulin has a positive 
effect on bovine follicular survival during in vitro culture at concentrations of 5 µg/mL in 
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culture media.  However, it was also shown that the addition of insulin can cause oocytes 
to prematurely achieve cytoplasmic maturation, before nuclear maturation is induced. 
In vitro culture of ovarian explants from prepubertal mice with R-spondin2, a 
paracrine factor, allowed for the development of preantral follicles from the primary stage 
to secondary follicles (Cheng et al., 2013).  R-spondin2 provides a potential future 
treatment option for infertile females.  In mice, in vivo administration of R-spondin2 to 
immature mice or those that were GnRH deficient, induced the development of primary 
follicles to the antral stage.  In addition, subsequent administration of equine chorionic 
gonadotropic (eCG) allowed for dominant, preovulatory follicle development, and an 
administration of human chorionic gonadotropin (hCG) induced ovulation.  Those oocytes 
released were competent and upon collection, were able to undergo successful in vitro 
fertilization (Cheng, 2013).  
 Oocytes ready for fertilization can be obtained either through superovulation and 
flushing of the oocytes, or via in vitro maturation of oocytes after follicle culture.  The 
source of follicles and oocytes for in vitro culture, when maturation and eventual 
fertilization of the oocyte is the goal, is very important.  Uchikura et al. (2010) has 
demonstrated that follicle size from which gametes are obtained, as well as the ovarian 
status from which the follicles are obtained, has a large effect on the maturational ability 
of feline oocytes.  For mature cats, those oocytes which are collected from larger follicles 
(1200-2000 µm in diameter) have a higher in vitro maturation rate than those collected 
from smaller, earlier stage follicles.  However, for oocytes isolated from smaller follicles 
(800-1200 µm in diameter) and cultured in maturation media in vitro, maturation rates were 
higher for those oocytes obtained from prepubertal cats, than from those obtained from 
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sexually mature cats.  It is now possible in many species, with limited efficiency, to grow 
preantral follicles up to antral stage (Yamamoto et al., 1999).   
Once oocytes have progressed to Metaphase II, fertilization with sperm (either fresh 
or cryopreserved) can be achieved either through in vitro fertilization, or through 
intracytoplasmic sperm injection, in which sperm are injected directly into the oocyte.  This 
has proven useful to rescue valuable genetics from males with less than ideal sperm, or 
from those suffering from teratospermia, which is the case with many wild felids (Uchikura 
et al., 2011).  After in vitro culture of embryos, they can be transferred to recipient females, 
where implantation, pregnancy and birth could result.  This has been achieved in many 
species using oocytes from antral follicles; however, live young have only been 
successfully produced from in vitro grown and matured oocytes derived from preantral 
follicles in mice (Eppig and Schroeder, 1989). 
 
     1.7.2.  Issues with ART 
 Some issues with ART arise simply because of stressors placed on donor animals.  
For example, heat stress has deleterious effects on the gametes of both female and male 
donors (e.g., DNA damage in epididymal sperm and lowered oocyte competence), as well 
as on early preimplantation embryos at the cleavage stage (Perez-Crespo et al., 2008; Ealy 
et al., 1993; Hansen, 2009).   In the summer when heat stress is most prevalent, the diameter 
of dominant follicles, total cholesterol, and concentrations of glucose and insulin like 
growth factor-1, as measured in the follicular fluid, in cows is significantly lower than in 
winter.  Conversely, concentrations of urea and non-esterified fatty acids are significantly 
higher in the summer than in winter (Shehab-El-Deen et al., 2010).  Age is another stressor 
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affecting fertility of the donor animal.  In mares, oocytes obtained from older donors result 
in significantly lower pregnancy rates after oocyte transfer and insemination. In addition, 
embryos produced via ICSI with oocytes from older donors result in decreased pregnancy 
rates after ET (Carnevale et al., 2010). 
Sustaining viability of selected follicles for culture, oocytes for fertilization, and 
embryos for transfer pose the largest hurdles for ART efficiency.  In the case of follicle 
culture, preantral follicles isolated from feline ovaries experience a drastic drop in viability 
immediately upon isolation (32.5%).  Depending upon the method of culture, follicle 
viability varies from 9.3% in conditioned medium to 37.5% with granulosa cell co-culture.  
Other culture methods examined included culture in monolayer (33.3% viability), in 
collagen gels (30.8%), and on an agarose pad (17.9%); generally, a slight increase in 
follicle size (10µm) was observed in the growing preantral follicles.  A decrease in 
granulosa cells surrounding the oocyte was detected, but this issue could be partially 
prevented with the addition of epidermal growth factor and insulin-transferrin-selenite to 
the culture media during in vitro culture (Jewgenow and Gӧritz, 1995).  Similar to these 
results, addition of EGF and FSH significantly increases maturation rate of buffalo oocytes 
during in vitro maturation (Raghu et al., 2002). Finally, cryopreservation of preantral 
follicles resulted in a reduction of viability to 40% (Jewgenow and Gӧritz, 1995).   
 It is likely that the low efficiencies of in vitro techniques are due, at least in part, to 
the inadequate provision of the correct compilation of substrates. This has been a long 
standing issue that largely results from a lack of knowledge regarding follicle, oocyte, and 
embryo metabolism and nutrient utilization.  There are several commercial media available 
for incubation; however, standardization of culture practices (e.g., culture media 
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composition, culture media practices, time in culture, culture temperature and atmospheric 
conditions) has not yet occurred in ART (Sepulveda et al., 2009;Biggers and Summers, 
2008; Nel-Themaat and Nagy, 2011).  This prevents comprehensive evaluation of ART 
efficiencies across species and sample types, but also across laboratories and clinics 
utilizing the same species and samples  
 
     1.7.3.  Selection of Viable Follicles, Oocytes, and Embryos for Use in ART 
  In order to overcome the issues of low efficiency, focus has shifted to finding 
biomarkers and other benchmarks for development, to determine which structures are of  
high quality and most likely to result in successful pregnancy and birth.  While 
morphologic assessment of oocytes and embryos are common, it has been asserted that 
morphologic assessment alone provides more information regarding poor quality oocytes 
than an indication of a good quality oocyte (Revelli et al., 2009). 
        
       1.7.3.1.  Oocytes and Follicles 
 Glucose-6-phosphate dehydrogenase (G6PDH) activity, measured by brilliant 
cresyl blue (BCB) dye, has been used as a marker for viability of oocytes in mice, buffalo, 
cattle, goats, and pigs.  High G6PDH activity is marked by an oocyte’s ability to process 
the stain, converting it from blue to colorless; low G6PDH activity results in an oocyte’s 
inability to covert the dye.  Furthermore, low G6PDH activity is linked to oocytes which 
have completed their growth phase.  Recently, Mohammadi-Sangcheshmeh et al. (2011) 
have demonstrated that those oocytes with low G6PDH activity have higher maturation 
rates than those with high G6PDH activity.  In addition, those oocytes with an expanded 
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cumulus complex, larger oocyte diameter, and higher oocyte volume have lower G6PDH 
activity. 
 Vascular endothelial growth factor (VEGF) has been implicated for use as a 
biomarker for oocyte maturation.  Studies of equine oocyte maturation in young and old 
mares have shown that, at least in older mares, levels of VEGF are significantly higher in 
mature oocytes than in immature or intermediate oocytes (Gündüz et al., 2011).  Levels of 
hormones, TGF-β, interleukins, and renin in the follicular fluid have also been proposed as 
potential biomarkers for follicle and subsequent oocyte viability (Arya, 2012). 
 
       1.7.3.2.  Embryos 
Historically, embryo developmental potential and viability have been determined 
by morphological assessment and cleavage rates.  While these two techniques have 
improved the efficiency of ARTs, they have proven to be insufficient to bring efficiency 
rates to an acceptable level, and have not alleviated the issue of multiple pregnancies (Seli 
et al., 2010).   
 Oxygen consumption by oocytes and embryos have been proposed as a primary 
screen for fertilization and developmental potential.  While further testing is necessary with 
respirometers before implementation in a clinical setting, current studies suggest that 
oocytes and embryos with higher oxygen consumption are correlated with higher 
fertilization rates, morphological quality, and pregnancy rates (Nel-Themaat and Nagy, 
2011). 
Metabolic markers of viability, as measured by ultra-micro fluorescence assays, 
have also been proposed.  While some contradictory results have been reported, the general 
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consensus is that early preimplantation embryos (cleavage stage and pre-compaction) are 
more reliant on carboxylic acids (i.e., pyruvate and lactate) for energy and carbon sources.  
Conversely, post-compaction morula and blastocysts switch to glucose utilization for 
energy and carbon (Seli et al., 2010; Nel-Themaat and Nagy, 2011).  This pattern has been 
observed in a number of species including humans, mice, rats, cattle, sheep, and pigs 
(reviewed by Ayinder et al., 2010). 
 More recently, a cross-disciplinary approach has been proposed, uniting DNA 
microarrays, transcriptomics (via proton nuclear magnetic resonance (1H NMR) 
spectroscopy), and metabolomics (via mass spectrometry (MS)) to provide an integrated 
approach to viability evaluation.  Results for individual tests correlated, and transcript 
profiles corresponded to metabolite accumulation trends over time (Soanes et al., 2011). 
 Preimplantation genetic screening employs genomic evaluation of embryos for 
viability.  These tests generally rely upon fluorescent in situ hybridization (FISH), and are 
invasive, requiring removal of cells from the preimplantation embryo (Seli et al. 2010).  
Unfortunately, evaluation by this method typically results in lower sustained implantation 
rates, instead of increasing the efficiency of ARTs.  Another analysis technique employs 
comparative genomic hybridization, which compares test DNA to “normal” control DNA, 
and can determine any instances of aneuploidy for all chromosomes.  Transcriptomic 
analysis has also been employed to evaluate RNA transcripts located in the embryo as well 
as in cumulus and granulosa cells from oocytes used for IVF, but is difficult due to the 
rapid degradation of RNA.  Proteomic evaluation has been explored; however, traditional 
methods are limited because of the amount of material needed for analysis.  New 
techniques utilizing mass spectrometry analysis are promising for identifying proteins in 
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oocytes, but, protein information in databases is limited for many larger animals like 
humans and livestock species (Seli et al., 2010).   
 
1.8.  Metabolomic Technologies  
Metabolomics is the systematic analysis of the metabolic fingerprint of cells, tissues 
and organs that represents their functional phenotype.  It can be more valuable and 
informative than its “-omics” technology predecessors (e.g., genomics, transcriptomics, 
and proteomics) because the metabolic information about the cell or tissue occurs 
downstream of genetic, enzymatic, and environmental controls.  Therefore, metabolomics 
provides a greater understanding of the metabolism of cells, after they have been subjected 
to both intrinsic and extrinsic control factors.  Untargeted metabolomics requires that 
identification and quantification is achieved in an unbiased manner for all metabolites 
present.  Metabolites are small (<1 kDa), non-proteinaceous compounds present in a 
biological sample, including ATP, hormones, signaling molecules, metabolic 
intermediates, and secondary metabolites, which contribute to the maintenance, growth, 
and normal function of cells.  The ultimate goal of metabolomics is to establish the 
metabolome, a complete profile of metabolites present in a sample or cell that defines the 
underlying dominance and connectivity of related metabolic pathways.  (Botros et al., 
2008; Seli et al., 2010; De la Luz-Hdez, 2012; McRae et al., 2013) 
 
     1.8.1.  Measurement and Identification of Compounds 
Metabolites by their nature are very diverse in type, chemical and physical 
properties, and in relative abundance.  The field of metabolomics is highly reliant upon 
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sample processing and procedure development to extract maximal quantities of metabolites 
and to yield highly reproducible analysis (Botros et al., 2008; De la Luz-Hdez, 2012; 
McRae et al., 2013).  No one processing procedure and analytical platform (eg., gas versus 
liquid chromatography) is capable of covering the diverse range of metabolites present in 
all types of samples (Niwa, 1995).  Extensive testing and optimization during development 
are necessary to determine the most appropriate processing approach and analytical 
platform suited for the sample type and the goal of the analysis.  Additionally, extraction 
and derivatization (if required by the platform) methods must be tested for suitability across 
metabolite classes (Sobolevsky et al., 2003; Koek et al., 2006; Madla et al., 2012).  
Derivatization methods routinely undergo testing and innovation to increase efficiency of 
derivatization (classes of compounds and completeness of derivatization) as well as the 
ease of preparation (Paik and Kim, 2004; Kouremenos et al., 2010). 
Metabolomics, although still in its infancy, has well established methods across 
many platforms.  Metabolomics platforms include nuclear magnetic resonance (NMR) 
spectroscopy, mass spectrometry, gas chromatography-mass spectrometry (GC-MS), high 
pressure liquid chromatography, liquid chromatography-mass spectrometry (LC-MS), near 
infrared spectroscopy, fourier transformation infrared spectroscopy, and raman 
spectroscopy for applications across disciplines (Botros et al., 2008; Ferreira et al., 2010; 
De la Luz-Hdez, 2012).  Mass spectrometry is a well-established platform for evaluation 
of drug-metabolite interactions and pharmacokinetics, and is now playing a larger role in 
metabolite profiling and characterization.  Its ability to accurately monitor normal 
physiological events (metabolites), makes it a powerful tool to detect even slight deviations 
that characterize diseased states.  Historically, GC-MS has been the preferred platform for 
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identification and quantification of metabolites.  Newer platforms including NMR and LC-
MS/MS have recently demonstrated advantages over GC-MS, including ease of sample 
preparation and expanded abilities to detect high and low molecular weight compounds 
(Want et al., 2005; Koek et al., 2010).  Nevertheless, numerous mass spectral libraries are 
available for compound identification with GC-MS, which offers a distinct advantage over 
other platforms. 
Generally, large sample volumes (>100 μL) are required for analysis on these 
platforms to obtain the minimum amount of each metabolite necessary for accurate 
detection (Koek et al., 2010).  However, sample size can be reduced through optimization 
of analytical platforms and innovative processing and derivatization techniques (Doherty, 
2003).  Indeed, recent studies report using “ultrasmall” samples with GC-MS and matrix 
assisted laser desorption ionization-mass spectrometry (Koek et al., 2010; Ferreira et al., 
2010).   
Many current platforms used for metabolomics offer high-throughput analysis 
when coupled with supporting software for metabolite identification (e.g., the National 
Institute of Standards and Technology (NIST), Fiehn, and Wiley libraries) allowing fast 
and easy analysis (Palazoglu and Fiehn, 2009; DeHaven et al.; Dunn et al., 2011).  Given 
the sheer quantity of platforms that can be used for metabolomics, as well as the breadth 
of compounds that can be analyzed, metabolomics has become a more accessible means to 






     1.8.2.  Metabolomics Applications 
 Metabolomics has been employed in a number of applications, from basic to 
biomedical and clinical research. 
Untargeted metabolomic analysis has been conducted on a variety of biological 
samples from blood serum and plasma, to plant material, and fungal and microbial 
populations to identify both common and uncommon metabolites (Roessner et al., 2000; 
Koek et al., 2006; Madla et al., 2012; Fiehn et al., 2000ab). 
Uses in the biomedical field have included cancer research, as well as the 
identification of disease biomarkers.  For example, mass spectrometry has elucidated basic 
metabolic pathways of rapidly proliferating cancer cells.  In particular, increased glycine 
uptake and mitochondrial glycine biosynthetic pathway activity is correlated with rapidly 
proliferating cancer cells.  Through this work, new targets for cancer therapies have been 
proposed (Jain et al., 2012).   
GC-MS has previously been used to evaluate serum, plasma, and urine samples.  
Metabolites in these biofluids are identified by retention time and ion fragmentation 
patterns of metabolites by comparison to spectral libraries and known standards.  Potential 
biomarker identification for pathologies as well as normal biological differences could be 
achieved through use of this platform (Pasikanti et al., 2008). 
1H NMR spectroscopy has been utilized to determine metabolic profile differences 
between induced pluripotent stem cells (iPSCs) and their parental somatic cells 
(fibroblasts) – iPSCs express a metabolite profile characterized by higher levels of 
glycolytic end-products that result from their markedly higher rate of glucose uptake and 
glycolytic activity (Folmes et al., 2011). 
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     1.8.3.  Metabolomics Applications in Reproduction 
Until recently, the main measure of embryo quality has been examination of 
morphological characteristics, which fails to yield high efficiency of ARTs.  Oxygen 
consumption, amino acid turnover, and time lapse videos of oocytes and/or embryos 
following in vitro maturation, fertilization, and culture have also been explored as methods 
of viability assessment.  A major shortcoming of many of these proposed methods of 
evaluation is that they often consider only a single biomarker, without regards to the 
“complete picture” of metabolism within the cells.  The implementation of metabolomic 
assessment of follicular fluid, oocytes, and embryos will allow for a more comprehensive 
understanding of potential biomarkers, as well as interactions between metabolites, which 
could serve as a biomarker(s) of viability (Revelli et al., 2009).  Metabolomics has 
implications in reproductive science to improve ART efficiencies.  While some have 
proposed the use of metabolomics to determine the physiological status and therefore the 
developmental potential and viability of oocytes and embryos, there is still limited 
application of this technology (Nel-Themaat and Nagy, 2011; McRae et al., 2013). 
 
       1.8.3.1.  Follicle and Oocyte Evaluation 
It is widely accepted that a contributing factor to the low efficiencies of ARTs is 
the inability to select oocytes with the highest competence and viability for fertilization.  
Metabolomics provides an objective, comprehensive method to noninvasively identify 
substantial quantities of small molecules which could serve as biomarkers for oocyte 
quality.  This concept has been explored in bovine and human oocytes and has been 
proposed for use in equine oocytes (Dell’ Aquila et al., 2012).  An issue to overcome with 
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metabolomic study is the accurate separation of cell types within the follicle.  Recently, a 
new dissection technique, Laser Capture Microdissection was developed by Bonnet et al. 
(2011).  This process was developed using ovine follicles of differing developmental 
stages, and was able to accurately separate granulosa cells and oocytes, even at the 
primordial follicle stage.  While researchers used this technique to separate cells for 
transcriptomics, it could easily be used for metabolomics to allow for accurate dissection 
of oocytes from granulosa cells for separate assessment. 
Metabolomic evaluation of oocytes can be achieved non-invasively by evaluating 
the follicular fluid aspirated from the follicle of origin or by evaluating spent culture media.  
For basic research and understanding, analysis of the follicular fluid is ideal as it contains 
secretions from the oocyte of interest, as well as from the granulosa cells enveloping it.  
However, for widespread clinical applications, isolation of individual follicles and 
individual aspiration of follicular fluid is impractical, so spent media evaluation provides 
an adequate alternative (Nel-Themaat and Nagy, 2011). 
 LC-MS evaluation of amino acid turnover by bovine oocytes has been utilized 
experimentally to determine differences between those oocytes which were able to cleave 
following in vitro fertilization and those that were not.  Competent oocytes depleted lower 
levels of glutamine from maturation medium, and released lower levels of alanine into the 
media as compared to incompetent oocytes (Hemmings et al., 2012).  Evaluation of 
glutamine utilization and production via metabolomics technologies is of particular 
interest.  Glutamine is a major carbon source for the TCA cycle (for ATP production and 
as an anapleurotic substrate), a contributor to glucose metabolism regulation, has protective 
properties against oxidative stress, and has the ability to contribute to the de novo synthesis 
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of other essential molecules.  Thus, glutamine has become a target as a metabolic 
biomarker of viability (Nel-Themaat and Nagy, 2011). 
 Metabolomic analysis of human follicular fluid has been achieved using 1H NMR 
spectroscopy and high resolution NMR platforms.  Intermediates of metabolic pathways 
including acetate, lactate, pyruvate, and glucose were positively identified in follicular 
fluid with high resolution NMR (Piñero-Sagredo et al., 2009).  Via 1H NMR analysis, 
distinct metabolic profiles were determined between uncleaved fertilized oocytes and 
fertilized oocytes which progressed.  In addition, metabolites which were discriminant 
between embryo stages, whether the corresponding oocyte was able to produce a one or 
two cell embryo, and between pregnancy outcomes were determined.  Fertilized oocytes 
which progressed to the two-cell stage had higher concentrations of lactate and 
choline/phosphocholine and lower intensities of glucose and high density lipoproteins than 
those that arrested as a one-cell zygote.  In those that resulted in a positive pregnancy, 
lactate, proline, and leucine/isoleucine concentrations were higher, while glucose 
intensities were lower.  Therefore, the developmental competence of human oocytes is 
correlated with the metabolite profile of the follicular fluid within its follicle (Wallace et 
al., 2012). 
 Following these findings, application of metabolomics in reproduction was 
proposed for the analysis of follicular fluid to determine oocyte quality of women with 
polycystic ovary syndrome (PCOS).  It is expected that in patients with PCOS, there is 
compromised glucose availability which forces follicles to use alternative energy sources 
to compensate (e.g., amino acid degradation, lipids, lactate, pyruvate).  It has been 
hypothesized that by identifying and quantifying the metabolites present, the level of 
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compensation can be determined; therefore, oocyte quality can be inferred (Arya et al., 
2012). 
 Fatty acid and lipid profiles, employing a metabolomics approach, have also been 
suggested as potential biomarkers of viability.  GC-MS based metabolomics has been 
employed in the analysis of bovine follicular fluid to determine differences in fertility 
between heifers and cows.  Follicular fluid has a distinct fatty acid composition between 
differing reproductive statuses, and a unique fatty acid composition as compared to serum.  
Cows have higher levels of palmitic and stearic acid (saturated fatty acids) in follicular 
fluid, while heifers have higher docosahexaenoic acid levels (Bender et al., 2010).  Matrix-
assisted laser desorption/ionization mass spectrometry has been utilized to analyze macro 
lipid profiles (triacylglycerols, phosphatidylcholines, and sphingomyelins) in a single 
human, bovine, ovine, and piscine oocyte, as well as in single bovine and insect embryos 
(Ferreira et al., 2010).  Desorption electrospray ionization-mass spectrometry has also been 
utilized by this group to monitor several classes of lipids (free fatty acids, 
phophatidylserines, phosphatidylcholines, and phosphatidylinositols) in single murine 
oocytes and embryos, in addition to bovine embryos (Ferreira et al., 2012). 
While comprehensive studies have been completed to analyze the nutrient 
compositions of follicular fluid in several livestock species (e.g., cattle), these have not yet 
been assessed in the cat (Bender et al., 2010; Campbell et al., 2010; Harris et al., 2009; 
Sutton-McDowall et al., 2010).  A recent study by Apparicio et al. (2010) has examined 
lipid profiles of feline oocytes, identifying phosphatidylcholines, sphingomyelins, and 
triacylglycerols.  As compared to canine oocytes, feline oocytes had higher levels of 52 
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and 54 carbon triacylglycerols with a higher number of unsaturated bonds, which indicated 
a high level of linoleic and oleic fatty acid residues. 
 
       1.8.3.2.  Embryo Evaluation 
Metabolomic evaluation of embryos provides two important advantages over 
existing ART embryo evaluation techniques.  First, it is a completely objective method of 
evaluation, unlike morphological assessment.  Secondly, it provides a high throughput 
method of analysis with Raman and near infrared spectroscopy which could be 
implemented in clinical settings (Nel-Themaat and Nagy, 2011). 
 Leese et al. (2007, 2008) assert that those embryos which exhibit the “quietest” 
metabolism are those that have the highest overall developmental potential.  However, even 
with a quiet metabolism, IVC embryos require energy sources and amino acids for growth 
and development.   
Metabolomic analysis of embryos has focused on pyruvate, glucose, and amino 
acid analysis of spent media, which provides a non-invasive evaluation of embryonic 
viability (Katz-Jaffe and McReynolds, 2011).   Viable embryos at earlier developmental 
stages (cleavage) rely heavily on TCA cycle activity for generation of ATP, while later 
developmental stages (compacted morula and early blastocyst) are characterized by a 
marked increase in glycolytic function (Nel-Themaat and Nagy, 2011).  Employing 
principal component analysis of 1H NMR spectral data of metabolites in preimplantation 
embryos, Naib et al. (2009) demonstrated that metabolites of 2 to 4 cell and 8 cell stage 
embryos clustered separately from those that had already undergone genome activation (16 
cell stage, morula, and blastocysts).  Amino acid uptake and release profiles, as evaluated 
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through metabolomic techniques, have also been suggested as markers for viability (Table 
1.2).   
 
Table 1.2:  Amino acid uptake and release corresponding to viable embryos in 
humans (reviewed by Ayinder et al., 2010) 
 Amino Acids 
Embryo Stage Uptake Release 
Zygote1 - 
Low:  Glycine, 
Leucine 
High:  Asparagine 
Zygote to 4-Cell 
Stage2 
- High:  Glutamate 
Zygote to 4-Cell 
Stage1 
Low:  Arginine, 
Glutamine, 
Methionine 
Low:  Alanine, 
Asparagine 
8-Cell, Morula3 Low: Serine 
Low: Alanine, 
Glycine 
 1 Houghton et al., 2002 
 2 Seli et al., 2008 




 Metabolomic analysis of spent culture medium from embryos (produced in vitro 
through ICSI) with known implantation results, has recently been used to develop models 
to predict implantation potential in humans (Cortezzi et al., 2013).  When subjected to 
validation tests, the model was able to predict the embryos that implanted with 100% 
probability, and was able to predict embryos that failed to implant with 70% probability.  
This suggests that non-invasive metabolomic analysis could eventually serve as an 
evaluation tool to increase ART efficiency.  Likewise, metabolomic profiling of embryo 
culture media via rapid near infrared spectroscopy has allowed for the development of a 
“viability model” (Seli et al., 2008).  This model exploits differences in isoleucine/leucine, 
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lactate, alanine, glutamate, pyruvate, and glucose levels between human embryos which 
implanted and resulted in live birth, and those embryos which did not result in a birth.  
When human embryos were scored by this model, varying scores were observed, even in 
embryos of similar morphological quality.  This result is not surprising and provides an 
explanation for consistently low ART efficiencies when morphologic assessment of 
embryos is the sole determinant of embryo viability (Sakkas et al., 2008).  
 Of particular interest to the goal of increasing ART efficiency is developing direct 
methods to evaluation the metabolism of oocytes and embryos.  While analysis of spent 
media has provided a non-invasive evaluation of embryos, this approach only provides an 
indirect measure of metabolism.  D’Alessandro et al. (2012) have employed a method 
utilizing aspirated blastocoele fluid where metabolites were identified and quantified using 
sample sizes as small as 0.5 nL.  While this method is invasive, it has been previously 
reported that collapsing the blastocoele by aspirating the blastocoele fluid actually 
improves survival and pregnancy rates after cryopreservation, thawing, and transfer 
(Mukaida et al, 2006). 
 
1.9.  Fluxomic Technologies 
Fluxomics, the newest “-omics” technology, builds upon metabolomics analysis 
through the use of stable isotope enriched compounds (“tracers”), thus allowing for the 
assessment of the biofunctionality of metabolic pathways.  Fluxomics ultimately yields 
quantitative measures of metabolic turnover or flux through operational pathways in a 
cell(s) (Zamboni and Sauer, 2009).  It has been used successfully to elucidate pathways in 
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multiple species, but most often it has been employed in microbial systems (Feng et al., 
2010; Kromer et al., 2009; Zamboni and Sauer, 2009).     
 This new technology exhibits several advantages over metabolomic analysis alone.  
While metabolomics can provide a static snapshot of the metabolic status of a cell, it 
provides limited information regarding its true physiologic status.  Fluxomics provides a 
dynamic picture of pathway activities in a cell, including specific metabolites which are 
derived from a tracer.  In addition, it allows for a more directed evaluation of metabolites 
by allowing for the elimination of “noise” compounds and for focus to be applied to 
downstream metabolites linked to the tracer (Hiller et al., 2010). 
 
     1.9.1.  Stable Isotope Tracers 
 Radioisotopes have been extensively used as tracers, but they possess several 
shortcomings, including their decay, complications with measurement of specific activity, 
and health and safety concerns.  The most common stable isotopes employed in biological 
systems are 13C, 15N, and 2H labeled organic compounds and metabolites.  Each stable 
isotope ion is either one or two mass units heavier than the most abundant natural isotope 
and can be incorporated into many different compounds (e.g., glucose, pyruvate, lactate) 
that are metabolically important.  These features allow for easy measurement via mass 
spectrometry, which measures the extent to which the stable isotope tracers are introduced 
into compounds.  Upon entry of the compound into the mass spectrometer, the analyte is 
subjected to an ionizing source which results in the predictable fragmentation such that 
fragment ions containing the incorporated stable isotope can be selectively monitored and 
their mass isotopomer distribution (MID) determined.  MID is calculated by quantifying 
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ion fragments containing stable isotopes as a ratio of the ion containing the unlabeled atoms 
and labeled atoms of interest (Table 1.3).  One caveat to utilizing stable isotope tracers is 
that the crude ion abundances calculated with this ratio must be corrected for the natural 
abundances (appearance) of the stable isotope atoms (giving the atom percent excess 
(APE)), the correction of which is easily performed utilizing many currently available 
multiple-linear regression softwares (Bequette et al., 2006). 
 The ability to integrate stable isotopes into a variety of compounds, as well as to 
integrate them in a specific manner to produce different isotopomers (e.g., [1,2-13C2] 
glucose versus [3-13C1] glucose) has produced a robust method to analyzing metabolic 
pathways.  Depending on the tracer selected, various pathways can be targeted for analysis.  
In mammals, [1,2-13C2] glucose is commonly used to probe the PPP, while [3-
13C1] glucose 
is often used to evaluate pyruvate oxidation.  Several tracers are used for evaluation of 
fluxes through the Krebs Cycle (Metallo et al., 2009). 
 
 
Table 1.3:  Crude mass isotopomer abundances (moles of tracer per 100 moles of 
tracee) for D-Glucose 
 
Quantity of each 
carbon isotope  
 
Mass Isotopomer 12C 13C 
Moles of 
Isotopomer 
[M+0] 6 0 100 
[M+1] 5 1 ([M+1]/[M+0])*100 
[M+2] 4 2 ([M+2]/[M+0])*100 
[M+3] 3 3 ([M+3]/[M+0])*100 
[M+4] 2 4 ([M+4]/[M+0])*100 
[M+5] 1 5 ([M+5]/[M+0])*100 





 While many compounds enriched with stable isotopes can be used as probes, the 
use of uniformly labeled 13C-glucose ([U-13C6] glucose) as a tracer will be the focus of this 
explanation, as it was the tracer employed in this thesis research.  Through the use of [U-
13C6] glucose and calculations of the APE for metabolic intermediates, it is possible to 
probe the fluxes through many pathways in central carbon metabolism.  Firstly, 
incorporation of an intact tracer molecule can be determined.  For example, if unlabeled 
and [U-13C6] glucose are employed, this will lead to synthesis of unlabeled and [U-
13C3] 
labeled pyruvate molecules upon glycolytic metabolism of glucose.  Secondly, 
incorporation of the 13C atoms into metabolites can only occur when these compounds are 
synthesized de novo by the cell or tissue upon metabolism of the labeled tracer.  In the case 
of the liver, if these labeled pyruvate molecules are eventually metabolized and contribute 
to gluconeogenesis, [M+3] glucose (i.e., three of the six carbons in glucose are 13C labeled) 
will result (Lee et al., 1991).   
  
     1.9.2.  Central Carbon Metabolism 
 Metabolic pathways are intrinsically connected within a cell, with the intermediates 
and products of one pathway serving as substrates or intermediates in linked pathways.  
With cells in culture, cellular intermediates are often released into the media and when 
their 13C-enrichment is determined, these released metabolites provide a direct measure of 
the cellular activity of the pathways from which they were derived.  Stable isotope tracers 
are used to exploit these two aspects of metabolism; therefore, providing information 
regarding the fluxes through linked pathways.  Amino acids linked to Krebs Cycle 
intermediates are summarized in Table 1.4 (Owen et al., 2002).  Pathways of interest in 
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central carbon metabolism, as well as substrates, intermediates, and products, are depicted 












Alanine, Cysteine, Glycine, Threonine, Tryptophan, 
Serine 
Acetyl-CoA 
Isoleucine, Leucine, Lysine, Phenylalanine, 
Threonine, Tryptophan, Tyrosine 
α-Ketoglutarate Arginine, Glutamate, Glutamine, Histidine, Proline 
Succinyl-CoA Isoleucine, Methionine, Valine 
Fumarate Phenylalanine, Tyrosine 






















Figure 1.3:  Connected pathways of carbon metabolism including Glycolysis, 
Gluconeogenesis, Pentose Phosphate Cycle (PPP), and the Krebs Cycle (TCA Cycle). 
Linked pathways of non-essential amino acid synthesis, fatty acid metabolism, and 
glycerol synthesis and degradation are also included.  Other abbreviations: Glucose-
6-Phosphate (G6P), Fructose-6-Phosphate (F6P), Glyceraldehyde-3-Phosphate 
(GAP), Dihydroxyacetone Phosphate (DHAP), Phosphoenol Pyruvate (PEP), Acetyl 
CoA (ACoA), alpha-Ketoglutarate (αKG), Oxaloacetate (OAA), Pyruvate 
Carboxylase (PC), Pyruvate Dehydrogenase (PD), Phosphoenolpyruvate 





A mixture of an unlabeled compound and a labeled tracer can be introduced to a 
biological sample through a variety of means, including incorporation into a fed diet, 
venous infusion, or incorporation into culture media for cells (Bequette et al., 2005).  Given 
a 50:50 mixture of unlabeled and [U-13C6] glucose:  upon entry to the cells the two 
isotopomers of glucose are processed in an unbiased fashion through the pathways of 
central carbon metabolism.  Based on known carbon rearrangements in the pathways, the 
theoretical enrichment of each intermediate can be determined (Mu et al., 2007).  
Furthermore, exploiting the fact that intermediates in carbon metabolism quickly achieve 
isotopic equilibrium with the non-essential amino acids (NEAAs) they synthesize, 
comparison of the determined MID for NEAAs to their theoretical enrichments allows for 
crude measures of the actual fluxes through pathways to be calculated (Berthold et al., 
2004). 
 Stable isotope tracer kinetics have been extensively reviewed; however, pertinent 
calculations related to 50:50 unlabeled and [U-13C6] glucose tracer infusions are 
summarized below (Bequette et al., 2005; Berthold et al., 1994; Metallo et al., 2009). 
 
       1.9.2.1.  Pyruvate 
 Pyruvate synthesized directly from glucose only via glycolysis will result in the 
production of only [M+0] and [M+3] pyruvate.  Pyruvate synthesized de novo from 
alternative carbon sources (e.g., amino acid degradation or glycerol) will result in a [M+0] 
pyruvate.  [M+1] and [M+2] pyruvate can derive from pentose phosphate pathway activity 




       1.9.2.2.  α-Ketoglutarate 
 [M+3] α-Ketoglutarate can only derive from [M+3] oxaloacetate (Carbons 2-4 
enriched) formed via pyruvate carboxylase.  [M+2] α-Ketoglutarate can be formed from 
[M+3] oxaloacetate (Carbons 1-3 enriched) in the first turn of the Krebs Cycle, [M+2] 
oxaloacetate in the second turn of the Krebs Cycle, or from entrance of [M+2] Acetyl CoA, 
derived from [M+3] or [M+2] pyruvate (Carbons 2 and 3 enriched). 
 
       1.9.2.3.  Oxaloacetate 
 [M+3] Oxaloacetate can be derived from [M+3] pyruvate via pyruvate carboxylase.  
[M+2] Oxaloacetate can be derived from [M+2] Acetyl CoA entrance to the TCA cycle on 
the first turn, or from [M+3] Oxaloacetate on the first turn.  [M+1] Oxaloacetate can 
originate from [M+3] Oxaloacetate on its second turn through the TCA cycle. 
 
       1.9.2.4.  Acetyl CoA 
 Acetyl CoA can derive from alternative carbon sources, such as amino acids or 
FAO, giving [M+0] Acetyl CoA.  It can also derive directly from pyruvate via pyruvate 
dehydrogenase.   
Of particular interest in studies is the amount of Acetyl CoA entering the Krebs 
Cycle.  Following the assumptions for origination of [M+2] and [M+3] α-Ketoglutarate, 
and that [M+3] oxaloacetate is in positional isotopomer equilibrium, the amount of Acetyl 
CoA entering the Krebs Cycle can be calculated as:   




     1.9.3.  Fluxomic Applications 
 The use of stable isotope tracers to determine flux through metabolic pathways have 
been employed in several different cell types and disciplines including industry and 
biomedical reasearch.  
 The field of bioengineering has seen exponential growth in recent years.  
Engineering organisms, particularly microorganisms and plant species with well-defined 
metabolic pathway maps, to utilize unimportant byproducts of industry and to produce 
compounds of interest has proven to be a very profitable endeavor.  In order to maximize 
production, the flux through biosynthetic pathways must first be monitored, and then in 
some cases, be altered, rerouting compounds to the pathways of interest.  Tracer studies 
have proven to be an invaluable tool for developing engineering strategies, as well as in 
evaluating engineered systems for production efficiency (Kajiwara et al., 1994; Iyer et al., 
2008). 
Enzyme kinetics are under constant scrutiny, whether in pursuit of basic 
biochemical knowledge, for evaluation of novel reactions, or as a potential biomedical 
therapy targets.  Stable isotope tracers provide an invaluable method for assessment of 
enzymatic reactions.  Questions regarding the reversibility of Isocitrate Dehydrogenase 
have been explored using [U-13C5] glutamate tracers.  After infusion, glutamate, in isotopic 
equilibrium with α-Ketoglutarate, could only result in [M+4] Citrate if all TCA cycle 
reactions occurred in the forward direction, whereas [M+5] Citrate could only occur if the 
reaction converting Isocitrate to α-Ketoglutarate was reversible.  Des Rosiers et al. (1994) 
demonstrated through the production of [M+5] Citrate, that the reaction catalyzed by 
Isocitrate Dehydrogenase is in fact reversible. 
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 Stable isotope tracers have also been utilized to evaluate the altered metabolism of 
immortalized cells.  [1,2-13C2] glucose inclusive media has been utilized to examine the 
effects of extracellular matrix detachment in immortalized, non-tumorogenic mammary 
epithelial cells.  It was found after analysis with GC-MS that detachment leads to a decrease 
in flux through glycolysis, the PPP, and through the TCA cycle.  Additionally, through 
examination of the abundances of [M+2] mass isotopomers of pyruvate and TCA cycle 
intermediates, it was determined that flux through pyruvate dehydrogenase (PDH) is 
decreased following detachment, which is consistent with findings that lactate synthesis 
and release increases in those cells.  Furthermore, through usage of [U-13C5] glutamate 
tracer, coupled with monitoring of TCA cycle intermediates, it was found that glutamate 
was unable to rescue the cells in response to decreased glucose carbon flux through the 
TCA cycle (Grassian et al., 2011). 
Cancer research has increasingly focused on metabolic differences between 
somatic cells which divide normally, and those cells which become cancerous.  In order to 
achieve this goal, stable isotope tracers have found increased use to assess differences in 
metabolic pathway flux in cancer cells.  13C-labeled glutamine has been used to show that 
cancer cells undergo reductive carboxylation of α-Ketoglutarate to form the majority of 
their lipogenic acetyl-CoA (Anastasiou and Cantley, 2012).  [U-13C6] glucose has been 
used to evaluate differences between rhabdomyosarcoma cells and primary myocytes, 
showing accelerated flux of glucose through glycolysis, as well as higher influx of 
anapleurotic substrates into the Krebs Cycle in cancerous cells (Fan et al., 2008). 
Pathologic conditions including nonalcoholic fatty liver disease (NAFLD) have 
also been explored using stable isotope tracers and fluxomic technologies.  13C and 2H 
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tracers were employed to evaluate mitochondrial metabolic pathways, lipolysis, and 
gluconeogenesis in affected and non-affected individuals.  Those with NAFLD had 30% 
higher rates of gluconeogenesis and 50% higher rates of lipolysis (Sunny et al., 2011). 
One challenge with fluxomic applications, particularly when positional isotopomer 
analysis is involved, is the accurate quantification of MID’s (therefore, the fluxes through 
interconnected pathways).  The development of software to automatically calculate flux 
values through pathways directly from platform output (e.g., from [13C, 1H] NMR data) 
has provided a way to complete high-throughput analysis (Sriram et al., 2004) 
 
     1.9.4.  Fluxomic Applications in Reproduction 
 While fluxomic technologies have been extensively applied in industrial, 
biomedical, and basic research in a variety of organisms, its potential has yet to be realized 
in mammalian reproductive applications.  This technology has yet to be applied to analyze 
the metabolic networks active in follicles and oocytes, and consequently to potentially 
identify viable oocytes for fertilization. 
 
1.10.  Discussion 
Given the need for a more comprehensive metabolic analysis of follicles, 
metabolomic and fluxomic analysis of these developmental structures is necessary.  It is 
the aim of this research to fill gaps in the understanding of follicle metabolism.  In 
particular, this thesis will focus on the shifts in metabolism through follicle development 
and environmental conditions that impact their metabolism.  Therefore, this investigation 
should provide novel insight into the changing nutrient needs of feline follicles and the 






Chapter 2:  Metabolomic Analysis of Feline Follicles 
 
 
2.1.  Introduction 
 The family Felidae encompasses 37 species, of which only the domestic cat is not 
threatened by extinction.  Wild species are under constant onslaught from habitat 
destruction and poaching.  Due to the rapid decline in populations, there have been 
increased conservation efforts fueled by management programs in zoological parks.  An 
invaluable facet to these programs is the use of ARTs to preserve and easily transport 
valuable genetics.  Unfortunately, ART efficiencies are still very low for many populations 
and research in felids to improve these methods is very limited (Bristol-Gould and 
Woodruff, 2006).   
 Past studies have examined follicle metabolism in several species, most of which 
are livestock animals.  Nevertheless, metabolite composition of follicular fluid has been 
shown to mirror changes in serum metabolite concentrations in cattle, suggesting that the 
follicle is highly dependent upon its environment for metabolic substrates (Leroy et al., 
2004b).  This is a critical observation that further supports the view that in order to improve 
ART efficiency, culture conditions must be improved to better support the metabolic needs 
of the follicle (or other reproductive structures).  The first step to improving culture 
conditions is defining the metabolism of developing follicles. 
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 Similar patterns in glucose, lactate, and pyruvate concentrations in follicles of 
different sizes have been observed in several species.  In sheep, buffalo, and dairy cows 
and heifers, glucose concentrations have been shown to be higher in large compared to 
small follicles.  Conversely, lactate concentrations decrease with stage of follicle growth 
and development (Leroy et al., 2004; Nandi et al., 2008; Nishimoto et al., 2009).  By 
contrast, pyruvate concentration does not appear to change with follicle size (Nandi et al., 
2008).  In one of the few studies with feline follicles, alanine, glutamine, and taurine were 
found in the highest concentrations in follicular fluid amongst the amino acids (Guerin et 
al., 2012).  While lipid abundance in follicles varies among species, palmitic and oleic 
acids have been shown to be the most predominant fatty acids in bovine and porcine COCs 
(Paczkowski et al., 2013).  Other products of metabolism including β-OHB, (total) 
cholesterol, and urea also vary according to follicle size, with β-OHB and total cholesterol 
increasing and urea decreasing with increasing follicle size (Leroy et al., 2004a). 
 Metabolomics provides a novel approach to analyze the metabolism of follicles by 
assessing the presence and abundance of a large range of metabolites (the metabolome) 
simultaneously.  Amino acids, energy substrates, and lipid profiles have been assessed for 
human and cattle follicles, as well as other species (Hemmings et al., 2012; Wallace et al., 
2012; Ferreira et al., 2012).  In the present study, metabolomics was utilized to characterize 
the metabolites present in feline follicles across stages of development (size) and 
developmental environments (in vitro culture).  By analysis of the composition of 
metabolites, we were also able to identify patterns of metabolism that characterize different 




2.2.  Rationale and Hypotheses 
 A comprehensive understanding of feline follicular metabolism is still lacking in 
reproduction science.  It is essential not only for basic knowledge, but also for eventual 
improvement of assisted reproductive techniques and advancement of in vitro culture 
procedures.  Differences in metabolite profiles will provide insights into fundamental 
metabolic differences between follicles of different developmental stages and growth 
environments, beyond the point of transcriptional, translational, and post-translational 
modification control. 
 Two comparisons are of interest in this study, (1) the metabolic differences between 
early and late antral follicles developed in vivo and (2) the metabolite differences between 
early antral follicles derived in vivo and those cultured in vitro.  It was expected that the 
metabolome would differ between stages of follicle development and between 
environmental conditions for development.  For statistical purposes, the null hypotheses 
are that there are no differences in the metabolite profiles of early and late antral follicles 
derived in vivo, or between early follicles derived in vivo and those cultured in vitro. 
 
2.3.  Materials and Methods  
     2.3.1.  Study Design:  Partial Block Design for Cat Age, Type 
 Three groups of follicles were identified for study:  early antral follicles originating 
in vivo, late antral follicles originating in vivo, and early antral follicles which were cultured 
in vitro for 12 d.  When possible, samples for each group were obtained from the same cat.  
Otherwise, cats of similar age (± 0.5yr) and type (housecat or stray cat) were paired and 




     2.3.2.  Follicle Collection and Storage 
Feline ovaries were acquired as a byproduct of routine ovariohysterectomies from 
a local spay clinic, Animal Birth Control, LLC, in central Maryland.  The paired ovaries 
from sexually mature cats (defined as at least one year old) were transported to the 
University of Maryland, College Park, on ice in phosphate buffered solution (PBS; Cellgro 
Mediatech, Manassas, VA).  Cortical slices were obtained from paired ovaries in warmed 
(38.5 °C) collection media (Table 2.1). Morphologically healthy, early antral (follicles 
<0.5 mm in diameter with a visible antrum) and late antral follicles (follicles >2 mm in 
diameter with a visible antrum) were mechanically isolated from ovaries as previously 
described (Jewgenow and Goritz, 1995).  Due to their smaller size, ten early antral follicles 
from each cat were pooled, washed through PBS, and stored at -80 °C until processing. For 
late antral follicles, a single follicle from each cat was washed through PBS and stored at -
80 °C until processing.  An additional ten early antral follicles from each cat were 
encapsulated as previously described (Songsasen, 2011).  Briefly, follicles were 
encapsulated  in 20 µL of 0.5% alginate hydrogel (Novamatrix, Sandvika, Norway), which 
was hardened in a calcium chloride solution (Table 2.2) for 3 min, washed through with 
maintenance media (Table 2.3), and cultured in individual wells of a 48-well plate (0.75 
cm2 growth area) with 500 µL of culture media (Table 2.4) for 12 d in 5% CO2 at 38.5 °C.  
Half of the culture media was refreshed every 72 hrs throughout incubation, with spent 
media being discarded.  On the final day of incubation, healthy follicles were mechanically 
isolated from their alginate drops in PBS, pooled, washed through PBS, and stored at -80 
°C until processing.    
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Table 2.1:  Composition and Company Source Information for Follicle Collection 
Media 
 
Follicle Collection Media:  Stored at 4°C, used at 38.5°C 
Medium 199 (TCM with Hepes) 
 
200mL Sigma Aldrich, St. Louis, MO 
L-Glutamine 
 
0.0584g Sigma Aldrich, St. Louis, MO 
Sodium Pyruvate:  
     100 mM Stock Solution 
 
2mL Gibco-Life Technologies, Grand 
Island, NY 
Penicillin G-Streptomycin Sulfate:   
     10,000 U/mL Penicillin;  
     10,000 µg/mL Stock Solution 
 
1mL Invitrogen-Life Technologies, 
Grand Island, NY 





Table 2.2:  Composition and Company Source Information for Calcium Chloride 
Solution 
 




Calcium chloride (anhydrous) 
 
0.277g Sigma Aldrich, St. Louis, MO 





Table 2.3:  Composition and Company Source Information for Maintenance Media 
 
Maintenance Media:  Stored at 4°C, used at 38.5°C 
Dulbecco’s Modified Eagle’s  
     Medium – low glucose 





0.0292g Sigma Aldrich, St. Louis, MO 
Penicillin G-Streptomycin Sulfate:  
     10,000 U/mL Penicillin;  
     10,000 µg/mL Stock Solution 
 
0.5mL Invitrogen-Life Technologies, 
Grand Island, NY 




Table 2.4:  Composition and Company Source Information for Follicle Culture 
Media. 
 
Follicle Culture Media:  Stored at 4°C, used at 38.5°C 
Dulbecco’s Modified Eagle’s  
     Medium – low glucose 
200mL Sigma Aldrich, St. Louis, MO 
 
 
L-Glutamine  0.0584g Sigma Aldrich, St. Louis, MO 
 
Insulin-Transferrin-Selenium:   
     25 mg/50 mL Insulin-Transferrin,  
     25 µg/50 mL Selenium Stock  
     Solution 





Penicillin G-Streptomycin Sulfate:  
     10,000 U/mL Penicillin;  
     10,000 µg/mL Stock Solution 




Bovine Serum Albumin 0.6g Rockland, Inc., Gilbertsville, PA 
   
Follicle Stimulating Hormone:   
     0.355 mg/mL Stock Solution 
563µL Sigma Aldrich, St. Louis, MO 
 
 
     2.3.3.  Sample Processing 
All samples were slowly thawed on ice (n=9 per group).  To each sample, 1 mL of 
ice-cold methanol:chloroform:water (5:2:2 v/v; VWR International, Radnor, PA; SP 
Mallinckrodt Baker, Phillipsburg, NJ) was added followed by homogenization on ice to 
disrupt cell membranes.  Next, samples were placed on a vortex mixer for an additional 15 
min, then incubated overnight at -80 °C for maximum metabolite extraction.  Following 
overnight incubation, samples were vortex mixed for 10 min, then centrifuged at 13,000 
xg for 10 min to remove cellular debris.  The supernatant was dried in a SpeedVac until 
completely dry.  Using the same tube, extracted metabolites were converted to their 
oximate-trimethylsilyl (TMS) derivative by addition of 60 µL of methoxylamine-HCl (30 
mg/mL in pyridine; Acros Organics, Waltham, MA;Thermo Scientific, Waltham, MA) 
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plus 60 µL of N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA) containing 1% 
trimethylchlorosilane (TCMS) (AlfaAesar, Ward Hill, MA), vortex mixing for 30 sec, and 
microwave heated for 120 sec at 200 watts.  Samples were then rotary mixed overnight to 
allow for maximum derivatization.  After overnight incubation, samples were transferred 
to glass gas chromatography vials prior to GC-MS analysis (Agilent, Palo Alto, CA).   
 
     2.3.4.  Gas Chromatography-Mass Spectrometry Analysis  
One microliter aliquots of samples were injected in split mode (2:1, inlet 
temperature of 250 °C) into the gas chromatographic system (Agilent 6890 gas 
chromatography system, Palo Alto, CA.; ZB50 capillary column) and separated on a mid-
polarity capillary column (ZB50; Phenomenex, Torrance, CA) under the following 
conditions:  initial temperature of 60 °C held for 5 min, heating 5 °C per min to 310 °C, 
hold for 5 min, cooling 50 °C per min to 60 °C and held for 5 min (70 min total run time). 
The MS (Agilent 5973 inert EI/CI MSD system, Palo Alto, CA) was operated in electron 
impact mode and ions monitored in full scan mode (mass range 50-650 m/z).  
GC-MS data files were captured via Agilent’s GC-MSD ChemStation, while 
Agilent Data Analysis software was used to view and quantitate the raw data files.  
Retention times and mass spectra of each entity was compared against the Agilent-Fiehn 
Mass spectral Library and cross-checked with the 2008 NIST Mass Spectral Library for 






     2.3.5.  Metabolite Abundance Calculations 
 The abundance of consistently identified metabolites was calculated as a proportion 
– the abundance of the given metabolite compared to the total abundance of all metabolites 
in the sample.  This was calculated by obtaining the total ion count for the given metabolite 
and dividing it by the total ion count for the total ion chromatogram for the entire sample.  
 
     2.3.6.  Statistical Analysis 
Files were analyzed with MetaboAnalyst software (online) for Partial Least Squares 
Discriminant Analysis (PLS-DA), while SAS was used to perform a mixed model analysis 
of variance (ANOVA) with Dunnett’s Correction (Xia et al., 2009; Xia and Wishart, 2011; 
Xia et al., 2012).  The following model was used: 
Yij = µ + Ti + Cj + €ij 
Yij = Response Variable (Lactic Acid, Alanine, etc.) 
µ = Grand Mean 
Ti = Treatment Effect (Early Antral, Late Antral, Early Antral in vitro) 
Cj = Random Effects (Block: age, type) 
€ij = Residual Error 
Significance was set at P < 0.05 (α = 5%).  Data was analyzed with the PROC MIXED 
procedure of SAS (SAS Ins, Inc., Cary, NC) with age/type as blocking factor.  For the 
analysis, follicle stage/type was considered a fixed effect, while cat age/type was a random 
effect.  Least squares means were obtained for each treatment and linear effects of follicle 
stage/type on the response variables were tested by constructing orthogonal contrasts.  
Pairwise mean comparisons were performed using the Dunnett’s Adjustment. 
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2.4.  Results 
 Over 100 entities were annotated using the NIST and Fiehn libraries.  Of those 
entities, 19 metabolites were positively identified and consistently present across samples 
in each group.  These metabolites (Table 2.5) ranged from amino acids, to organic and 
fatty acids, to sterols and carbohydrates, and were involved in a variety of metabolic 
pathways.  Early antral follicles undergoing in vitro culture were between 300 and 500 µm 
upon collection from the ovary.  The largest follicles upon collection after incubation were 
625 µm in diameter. 
 
 
Table 2.5:  Metabolites identified in follicles by comparison to established metabolite 
libraries 
Metabolite  Approximate 
Retention Time 
L-Alanine  14.45 
Cholesterol  56.08 
Citrate  32.97 
L-Glutamate  28.69 
Glycine  19.94 
L-Lactate  13.61 
L-Leucine  19.00 
Linoleic Acid  41.15 
D-Malate  25.77 
Myo-Inositol  35.31 
Oleic Acid  41.04 
Palmitic Acid  37.42 
L-Proline  22.18 
Pyruvate  15.05 
L-Serine  20.59 
Stearic Acid  40.88 
Succinate  22.44 
L-Threonine  21.18 




     2.4.1.  Metabolomics of in vivo derived follicles 
In late antral follicles, cholesterol was the most abundant metabolite and its 
concentration was higher (P <0.0001) than in early antral follicles.  Likewise, myo-inositol 
was in higher (P < 0.0005) concentrations in late compared to early antral follicles.  
Amongst the amino acids, proline varied the most with stage, and its concentration was 
higher (P < 0.001) in late compared to early antral follicles.  Pyruvate was the only 
metabolite that was in lower (P <0.0001) concentrations in late compared to early antral 
follicles.  With the exception of succinate, palmitate, stearate, leucine, serine, and valine, 
there was a general tendency for the remaining identified metabolites to be more enriched 
in late compared to early antral follicles (Table 2.6).  Metabolites differing significantly in 
concentration between early and late antral follicles are summarized in Figure 2.1 (A).  
When subjected to a PLS-DA, metabolites from early and late antral follicles 
formed two clusters with some overlap (95% confidence interval) in a two dimensional 
plot (Figure 2.2).  When three components of variation were considered, early and late 
antral follicles formed two distinct clusters (Figure 2.3). 
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Table 2.6:  Relative proportions of metabolites in early and late antral follicles derived 








Alanine 0.11 ± 0.02 0.11 ± 0.03 0.9997 
Cholesterol 5.87 ± 1.11 19.85 ± 2.90 <0.0001* 
Citrate 0.26 ± 0.08 0.36 ± 0.08 0.4962 
Glutamate 0.33 ± 0.06 0.37 ± 0.07 0.9070 
Glycine 0.98 ± 0.23 1.14 ± 0.24 0.7783 
Lactate 4.34 ± 0.74 6.32 ± 0.39 0.0859 
Leucine 0.14 ± 0.03 0.09 ± 0.03 0.3175 
Linoleic Acid 0.26 ± 0.09 0.47 ± 0.08 0.1243 
D-Malate 0.10 ± 0.01 0.20  ± 0.04 0.0751 
Myo-Inositol 0.15 ± 0.04 0.55 ± 0.06 0.0003* 
Oleic Acid 0.14 ± 0.03 0.19 ± 0.02 0.2973 
Palmitic Acid 2.65 ± 0.57 2.35 ± 0.18 0.6774 
Proline 0.02 ± 0.01 0.35 ± 0.09 0.0009* 
Pyruvate 0.50 ± 0.02 0.21 ± 0.06 <0.0001* 
Serine 0.11 ± 0.02 0.09 ± 0.04 0.9233 
Stearic Acid 2.48 ± 0.80 2.25 ± 0.20 0.9078 
Succinate 0.40 ± 0.04 0.33 ± 0.05 0.4872 
Threonine 0.00 ± 0.00 0.01 ± 0.00 0.4120 
Valine 0.15 ± 0.03 0.12 ± 0.04 0.9117 
1Values reported as least squares means, plus or minus the standard error of the mean 









Figure 2.1:  Metabolites found in significantly different concentrations between in vivo 
derived early and late antral follicles (A), between in vivo derived and in vitro cultured 
(IVC) early antral follicles (B), and between in vivo derived late antral follicles and in 
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Figure 2.2:  Two-dimensional PLS-DA of early (dark gray) and late (light gray) 
antral follicles, with a 95% confidence interval indicated around each cluster.  The 
variation between samples captured by each component is indicated in parenthesis 


























Figure 2.3:  Three-dimensional PLS-DA of early (dark gray) and late (light gray) 
antral follicles. The variation between samples captured by each component is 
































Component 1 (32.5%) 
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2.4.2.  In vivo derived versus in vitro cultured early antral follicles  
 Of those metabolites monitored for in vivo derived early antral follicles and those 
cultured in vitro, only 3 of 19 metabolites differed.  In contrast to the differences observed 
between in vivo derived early and late antral follicles, the differences between in vivo and 
in vitro derived follicles were only evident in the proportional abundance of amino acids.  
Threonine, valine, and serine were all in higher proportions (P <0.001, P <0.005, and P 
<0.01, respectively) in those follicles cultured in vitro compared to in vivo derived and 
analyzed follicles.  With the exception of cholesterol, citrate, palmitate, and stearate which 
were all slightly lower in in vitro cultured follicles, there was an overall tendency for the 
remaining metabolites to be equivalent to or slightly higher in in vitro derived follicles 
(Table 2.7).  Metabolites differing significantly in concentration between in vivo derived 
early and in vitro cultured early antral follicles are summarized in Figure 2.1 (B). 
 Upon analysis of the samples using PLS-DA, samples from each group clustered 
together when plotted in two-dimensions; however, given a 95% confidence interval for 
each group, there is major overlap between the two groups (Figure 2.4).  When plotted in 
a three-dimensional space, using the three major components of variation for the data, early 
antral follicles derived in vivo and early antral follicles cultured in vitro formed two distinct 






Table 2.7:  Relative proportions of metabolites in in vivo derived early antral follicles 









Alanine 0.11 ± 0.02 0.11 ± 0.03 0.9848 
Cholesterol 5.87 ± 1.11 3.58 ± 0.61 0.5162 
Citrate 0.26 ± 0.08 0.19 ± 0.05 0.7254 
Glutamate 0.33 ± 0.06 0.44 ± 0.07 0.4247 
Glycine 0.98  ± 0.23 1.39 ± 0.16 0.2384 
Lactate 4.34 ± 0.74 6.20 ± 0.88 0.1084 
Leucine 0.14 ± 0.03 0.20 ± 0.04 0.2670 
Linoleic Acid 0.26 ± 0.09 0.32 ± 0.05 0.8168 
D-Malate 0.10 ± 0.01 0.10 ± 0.02 0.9906 
Myo-Inositol 0.15 ± 0.04 0.30 ± 0.05 0.1573 
Oleic Acid 0.14 ± 0.03 0.14 ± 0.02 0.9994 
Palmitic Acid 2.65 ± 0.57 2.32 ± 0.31 0.6171 
Proline 0.02 ± 0.01 0.01 ± 0.01 0.9986 
Pyruvate 0.50 ± 0.02 0.52 ± 0.03 0.9096 
Serine 0.11 ± 0.02 0.31 ± 0.07 0.0085* 
Stearic Acid 2.48 ± 0.80 2.15 ± 0.35 0.8209 
Succinate 0.40 ± 0.04 0.39 ± 0.08 0.9707 
Threonine 0.00 ± 0.00 0.05 ± 0.01 <0.0001* 
Valine 0.15 ± 0.03 0.49 ± 0.11 0.0025* 
1Values reported as least squares means, plus or minus the standard error of the mean 






Figure 2.4:  Two-dimensional PLS-DA of early antral follicles collected directly from 
feline ovaries (dark gray) and early antral follicles cultured in vitro (light gray), with 
a 95% confidence interval indicated around each cluster.  The variation between 
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Figure 2.5:  Three-dimensional PLS-DA of early antral follicles collected directly 
from feline ovaries (dark gray) and early antral follicles cultured in vitro (light gray). 
The variation between samples captured by each component is indicated in 
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2.4.3.  In vivo late antral follicles versus in vitro cultured early antral follicles 
In late antral follicles, cholesterol was the most abundant metabolite and its 
concentration was higher (P =0.0004) than in in vitro cultured early antral follicles.  
Likewise, myo-inositol was in higher (P =0.0315) concentrations in late antral follicles 
compared to in vitro cultured early antral follicles.  Pyruvate was found in lower (P 
=0.0005) concentrations in late antral follicles compared to in vitro cultured early antral 
follicles.  Amongst the amino acids, proline was the only amino acid found in higher 
concentrations (P =0.0052) in late antral compared to in vitro cultured early antral follicles.  
Leucine, serine, threonine, and valine were all found in lower concentrations (P =0.0082, 
P =0.0198, P =0.0031, P =0.0076, respectively) in late antral follicles as compared to in 
vitro cultured early antral follicles.  There was a general tendency for the identified fatty 
acids and TCA cycle intermediates, with the exception of succinate, to be more enriched 
in late antral compared to in vitro cultured early antral follicles (Table 2.8).  Metabolites 
differing significantly in concentration between in vivo derived late antral and in vitro 
cultured early antral follicles are summarized in Figure 2.1 (C). 
When subjected to a PLS-DA, metabolites from late antral follicles and in vitro 
cultured early antral follicles allowed for formation of two clusters with some overlap (95% 
confidence interval) in a two dimensional plot (Figure 2.6).  When three components of 
variation were considered, the groups formed two distinct clusters (Figure 2.7). 
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Table 2.8:  Relative proportions of metabolites in in vitro cultured early antral follicles 





(in vitro cultured) 
Late Antral 
(in vivo) 
Alanine 0.11 ± 0.03 0.11 ± 0.03 0.8789 
Cholesterol 3.58 ± 0.61 19.85 ± 2.90 0.0004* 
Citrate 0.19 ± 0.05 0.36 ± 0.08 0.0755 
Glutamate 0.44 ± 0.07 0.37 ± 0.07 0.5060 
Glycine 1.39 ± 0.16 1.14 ± 0.24 0.4197 
Lactate 6.20 ± 0.88 6.32 ± 0.39 0.9149 
Leucine 0.20 ± 0.04 0.09 ± 0.03 0.0082* 
Linoleic Acid 0.32 ± 0.05 0.47 ± 0.08 0.0695 
D-Malate 0.10 ± 0.02 0.20  ± 0.04 0.0764 
Myo-Inositol 0.30 ± 0.05 0.55 ± 0.06 0.0315* 
Oleic Acid 0.14 ± 0.02 0.19 ± 0.02 0.0878 
Palmitic Acid 2.32 ± 0.31 2.35 ± 0.18 0.8448 
Proline 0.01 ± 0.01 0.35 ± 0.09 0.0052* 
Pyruvate 0.52 ± 0.03 0.21 ± 0.06 0.0005* 
Serine 0.31 ± 0.07 0.09 ± 0.04 0.0198* 
Stearic Acid 2.15 ± 0.35 2.25 ± 0.20 0.7028 
Succinate 0.39 ± 0.08 0.33 ± 0.05 0.3074 
Threonine 0.05 ± 0.01 0.01 ± 0.00 0.0031* 
Valine 0.49 ± 0.11 0.12 ± 0.04 0.0076* 
1Values reported as least squares means, plus or minus the standard error of the mean 








Figure 2.6:  Two-dimensional PLS-DA of in vitro cultured early antral (dark gray) 
and in vivo derived late (light gray) antral follicles, with a 95% confidence interval 
indicated around each cluster.  The variation between samples captured by each 








Figure 2.7:  Three-dimensional PLS-DA of in vitro cultured early antral (dark gray) 
and in vivo derived late (light gray) antral follicles.  The variation between samples 
captured by each component is indicated in parenthesis on each axis. 
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2.5.  Discussion 
 Folliculogenesis is a highly coordinated and energy-dependent process; however, 
the means by which follicles and oocytes obtain and process energetic substrates is not well 
understood.  Previous studies exploring follicle metabolism in humans and domestic 
species have relied upon a limited number of exogenous substrates in spent media.  These 
studies have provided invaluable information regarding the metabolism of follicles, but are 
hindered by their limited scope and indirect measurement.  Recent applications of 
metabolomic technologies to assess follicle, oocyte, and COC metabolism in human and 
livestock species have provided a more robust method for metabolic evaluation (Revelli et 
al., 2009).  The objective of this study was to use refined methods of derivatization and 
evaluation of follicular samples via GC-MS to (1) evaluate intrinsic metabolic differences 
exhibited by feline follicles of different developmental stages, as well as to (2) assess the 
influence of in vitro culture on the metabolic profile of follicles of the same developmental 
stage.  To address these objectives, early (< 0.5 mm) and late antral follicles (> 2.0 mm) 
were isolated from reproductively mature females for comparison.  In addition, early antral 
follicles were subjected to long-term (12 d) in vitro culture, which should have given the 
follicles ample time to progress to the late antral stage; however, only minor growth 
occurred.  Previous studies have shown that follicles undergo shifts in substrate utilization 
and thus metabolism throughout development; understanding the metabolic basis for these 
shifts, as well as their effect on oocyte maturation and fertilization potential, has been 





     2.5.1.  Lipids:  Fatty Acids, Cholesterol 
The lipid and fatty acid profile of follicular fluid has been shown to vary between 
species (Sturmey et al., 2009).  In the current study, the predominant fatty acids detected 
in feline follicles were palmitic, stearic, oleic, and linoleic acid.  Significant changes among 
fatty acid composition in groups were not observed, however.  This is in line with previous 
reports that non-esterified fatty acid concentrations in the follicular fluid do not vary with 
bovine follicle size (Leroy et al., 2004b).  Stearic and palmitic acid were the most abundant 
of the four fatty acids in the feline follicles.  The most abundant fatty acid observed in cow 
oocytes was palmitic acid; in sheep, oleic acid; in pigs, palmitic and oleic acids. By contast, 
in humans, stearic acid has been reported to be the most abundant fatty acid (Paczkowski 
et al., 2013).  Of the polyunsaturated fatty acids, linoleic and arachidonic acid are the most 
abundant in cattle, pig, and sheep denuded oocytes (McEvoy et al., 2000).  While feline 
follicle fatty acid profiles have not been examined previously, the findings from the current 
study reflect fatty acids found in the follicular fluid of other species.  In addition, pervious 
reports show that linoleic and oleic acids are present in feline oocytes, which is consistent 
with the current results (Apparicio et al., 2012).  Given the essentiality of fatty acid 
oxidation for energy production and oocyte nuclear maturation, it is not surprising that 
saturated fatty acids were found in the highest concentrations (Sturmeyet al., 2009). 
In bovine follicular fluid, total cholesterol has been reported to increase from 1.45 
(±0.09) to 1.65 (±0.08) mM between small (< 4 mm) and large (> 10 mm) follicles (Leroy 
et al., 2004a).  In accordance with these findings, cholesterol was most abundant amongst 
the metabolites in feline follicular fluid, and its relative concentration was higher in late 
(20%) compared to early (6%) antral follicles and in vitro cultured early (4%) antral 
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follicles.  Cholesterol in follicular fluid is primarily bound to high density lipoproteins 
(HDLs) as other lipoproteins are too large to pass across the blood-follicle barrier.  
Furthermore, due to the increased permeability of the follicular wall in late compared to 
early stage follicles, the increase in cholesterol is likely due to an increased uptake of HDL 
(Leroy et al., 2004a).  Cholesterol also plays a key role in steroid hormone biosynthesis; 
of these hormones, progesterone is produced in high amounts by corpora lutea, formed 
from the remains of ovulatory follicles and is required to maintain pregnancy.  The 
proportion cholesterol tended to decrease, although not significantly, during in vitro culture 
of early antral follicles. 
 
2.5.2.  Lactate and Pyruvate 
 Most studies have measured follicular fluid concentrations of glucose, lactate, and 
pyruvate as indicators of follicle metabolic status.  Across species, decreased glucose, 
increased lactate, and no difference in pyruvate concentrations are observed in follicular 
fluid of large versus small follicles (Nandi et al., 2008).  In the present study, lactate tended 
to comprise an increased proportion of all metabolites in in vivo derived late antral follicles 
and early antral follicles cultured in vitro as compared to in vivo derived early antral 
follicles.  The proportion of pyruvate did not change significantly between early antral 
follicles derived in vivo and those cultured in vitro; however, pyruvate comprised a 
significantly lower proportion of metabolites in late antral follicles compared to in vivo 
derived and in vitro cultured early antral follicles.  While these results appear to contradict 
previous findings in follicular fluid, it is most likely due to the fact that slightly different 
samples were collected.  Granulosa cells are known to metabolize glucose to pyruvate and 
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lactate, which the oocyte utilizes as an energy substrate.  It is possible that pyruvate is 
released to the follicular fluid in similar concentrations between follicles sizes, but that the 
oocytes of late antral follicles metabolize pyruvate to other metabolites at higher rates, 
accounting for the lower detected abundance.  In addition, abundances in this study are not 
absolute concentrations, so it is possible that there are significantly more metabolites 
present in late antral follicles and that the absolute concentration of pyruvate is not different 
between follicle sizes.   
Alternatively, in previous studies of follicle size, pyruvate concentrations were 
found to be lower compared to lactate (Nandi et al., 2008).  This finding is reflected in the 
present study where pyruvate contributions to the total metabolite pool were much lower 
than lactate within a given size of follicle.  In in vivo derived early antral follicles, lactate 
accounted for 4.3% of all metabolites, while pyruvate constituted only 0.5% of the same 
pool.  For late antral follicles, lactate constituted 6.3% of all metabolites, while pyruvate 
contributed only 0.2%.  In vitro culture of early antral follicles results in 6.2% and 0.5% 
contributions of lactate and pyruvate, respectively.   
 
     2.5.3.  Amino Acids 
 No significant differences in the proportion of amino acids in the metabolite profile 
were detected between follicles of different developmental stages in vivo.  However, serine, 
threonine, and valine were higher in early antral follicles that had been cultured in vitro 
compared to in vivo derived early antral follicles.  This was mirrored in the comparison of 
in vitro cultured early antral follicles to in vivo derived late antral follicles, although leucine 
was also higher in in vitro cultured early antral follicles.  It is well documented that 
79 
 
follicles, oocytes, and COCs are very susceptible to changes in their micro-environments.  
Given that these four amino acids were included in culture media at supraphysiological 
concentrations (Table 2.9), and that leucine, threonine, and valine are essential amino acids 
that can only be obtained from the environment, it is probable that in vitro cultured follicles 
were simply able to take up higher amounts of these amino acids than their in vivo derived 
counterparts due to their higher availability and were concentrated within the follicle.  This 
pattern was mirrored in glutamate and glycine which tended to be higher in cultured 
follicles than those derived directly from the cat, while proline and alanine tended to be 
roughly equivalent.  Glyine and glutamine (i.e. a precursor of glutamate) were all included 
in the culture media, while alanine and proline, which did not vary across treatments, had 
not been included. 
 
 
Table 2.9:  Physiological and Media concentrations of selected amino acids 
 Concentrations (mM) 
Amino Acid Feline Serum2 Culture Media1 
Alanine 0.256 0.000 
Glutamate 0.053 0.000 
Glutamine 0.190 2.000 
Glycine 0.100 0.400 
Leucine 0.034 0.802 
Proline 0.053 0.000 
Serine 0.050 0.400 
Threonine 0.054 0.798 
Valine 0.064 0.803 
1 Current Study 





 Previous studies with feline follicles have established the amino acid concentrations 
in tubal fluid and late antral (2-3 mm) follicular fluid employing HPLC.  However, cross-
stage developmental comparisons have not been performed.  Alanine, taurine, glutamine, 
and glutamate have been reported to be the most abundant amino acids in follicular fluid, 
while evaluation of feline tubal fluid revealed that glycine, glutamate, and taurine were the 
highest (Guerin et al., 2012).  Each amino acid detected in this study is represented as a 
percent of all detected amino acids, for the current and previous data in Table 2.10.   Amino 
acid profiles of late antral follicles determined in this manner are quite different for this 
study compared to Guerin et al. (2010).  Alanine, glutamate, and glycine were the most 
abundant in the previous report, while glycine, glutamate, proline were the most abundant 
in late antral follicles in the present study.  Possible sources of differences could be a result 
of the different sampling methods.  Granulosa and theca cells, as well as oocyte 
contributions to the amino acid profile, in addition to the follicular fluid (exclusively 
examined in the Guerin study), were examined in the current study.  It is possible, for 
example, that glycine is found in elevated concentrations in the oocyte and follicular cells, 


















Table 2.10:  Percent abundance of detected amino acids  
 




(in vivo) 1 
Late Antral 
(in vivo) 2 
Alanine 4.82 29.21 
Glutamate 16.23 20.83 
Glycine 50.00 18.23 
Leucine 3.95 3.99 
Proline 15.35 5.70 
Serine 3.95 7.24 
Threonine 0.44 6.92 
Valine 5.26 7.89 
TOTAL 100 100 
1 Current Study 
2Guerin et al., 2002 
 
 
     2.5.4.  MyoInositol 
 No differences in myo-inositol, as a proportion of all metabolites, was detected 
between in vivo derived early antral follicles and those cultured in vitro.  However, myo-
insositol comprised a higher proportion of the metabolite profile in late antral follicles than 
in in vivo derived and in vitro cultured early antral follicles. 
 Inositol is a fundamental structural component of signaling molecules implicated 
in the process of fertilization.  In felids, myo-inositol serves as a substrate for the 
biosynthesis of inositol-phosphate compounds, including phosphatidylinositol 4,5-
bisphosphate (PIP2).  PIP2 is a phospholipid localized in the plasma membrane of oocytes, 
which is hydrolyzed upon binding with phospholipase C after fertilization, producing 
diacylglycerol and inositol trisphosphate (IP3) (White et al., 2010). The resulting IP3 serves 
a secondary messenger, which upon binding to IP3 receptors, initiates the release of calcium 
from the endoplasmic reticulum to prevent polyspermy (Runft et al., 1999; Wagner et al., 
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2004).  Decreased expression of type 1 IP3 receptors has been implicated in the reduced 
fertility of cryopreserved oocytes (Hirose et al., 2013).  Given this information, it is not 
surprising that throughout growth, the oocyte accumulates myo-inositol for eventual 
biosynthesis of PIP2.  It is reasonable to assume that late antral follicles, containing oocytes 
poised for fertilization, would contain higher levels of myo-inositol than early antral 
follicles. 
 
     2.5.5.  TCA Cycle Intermediates 
 No difference between follicle developmental stage or developmental 
environments (in vivo versus in vitro) were detected for the Krebs cycle intermediates 
citrate, malate, and succinate.  This finding was somewhat unexpected, given that one 
would expect elevated Krebs cycle activity (i.e., oxidation, ATP synthesis) to support the 
increased energy demands of the follicle. However, it does not appear that the proportion 
of these compounds to the entire metabolite profile is altered.  This would be expected 
given that these compounds are both synthesized and utilized in this circular pathway.  The 
constant need to produce and to use these metabolites would favor regulation over a 
buildup or deficiency. 
 
     2.5.6.  Partial Least Squares-Discriminant Analysis 
 Given that groups cluster together when analyzed via 2-D and 3-D PLS-DA, 
metabolomics offers a means to classify follicles on a metabolic basis.  However, the 
overlap observed in 2-D PLS-DA plots suggests the need to identify additional metabolites 
to further discriminate the classes of follicles.  A comparative analysis of atretic follicles 
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or of follicles producing oocytes of known maturational ability, when aided with these 
additional biomarkers, could be a more definitive approach for identifying healthy follicles 
and viable oocytes. 
 Similarity of the early antral follicles cultured in vitro to those derived in vivo and 
the marked difference to late antral follicles, in both size (growth throughout in vitro culture 
was minimal) and in metabolite profile after lengthy culture which gave the follicles 
sufficient time to progress suggests that in vitro cultured early antral follicles are not 
shifting to the metabolism expressed by late antral follicles.  It is possible that 
improvements to follicle culture media formulations are needed in order to allow for this 











Chapter 3:  Fluxomic Analysis of Feline Follicles 
 
 
3.1.  Introduction 
 The family Felidae encompasses 37 species, of which only the domestic cat is not 
endangered or threatened by extinction.  A rapid decline in wild populations has been 
experienced, mainly due to constant onslaught from poaching and habitat destruction.  
Recently, conservation management programs in zoological parks have sparked 
exploration into expanding the use of ARTs to preserve and easily transport valuable 
genetics.  Unfortunately, ART efficiencies are still very low for many populations and 
research in felids to improve these methods are very limited (Bristol-Gould and Woodruff, 
2006).   
 Past studies have examined follicle metabolism in livestock species.  In these 
studies, the metabolite composition of follicular fluid has been shown to mirror changes in 
serum metabolite concentrations in cattle, suggesting that the follicle is highly dependent 
upon its environment for metabolic substrates (Leroy et al., 2004b).  This justifies the 
assertion that in order to improve ART efficiencies, culture conditions must be improved 
to better serve the metabolic needs of the follicle (or other reproductive structure).  The 
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first step to improving culture conditions is achieving a better understanding of the 
metabolic status of the follicles to be cultured. 
 Static snapshots of follicular metabolism have been gleaned from photometric 
assays and metabolomic analysis as in Chapter 2.  Similar patterns in concentrations of 
glucose and lactate in follicles across sizes have been observed in several species including 
sheep, buffalo, and dairy cows and heifers, and in the case of lactate, with cats.  Glucose 
concentrations are higher in large compared to smaller follicles, while lactate 
concentrations are lower, or tend to be lower, as was shown in cats (Leroy et al., 2004; 
Nandi et al., 2008; Nishimoto et al., 2009).  Pyruvate, unlike glucose and lactate, does not 
appear to change in concentration across follicle sizes (Nandi et al., 2008).  While lipid 
profiles and abundances vary in follicles from different species, palmitic and oleic acids 
have been shown to be some of the most prevalent fatty acids in bovine and porcine COCs 
(Paczkowski et al., 2013).  Other products of metabolism including (total) cholesterol and 
urea also vary according to follicle size, with total cholesterol increasing and urea 
decreasing as follicle size increases (Leroy et al., 2004a).  Unfortunately, examining the 
presence or absence of metabolites in a sample does very little to provide a dynamic picture 
of a cell’s physiologic state.   
 Enhanced glycolytic activity is an essential aspect of many rapidly growing and 
developing cells, including the oocyte and follicle. However, although glucose uptake 
increases during in vitro oocyte maturation, glycolytic rates of COCs as assessed by lactate 
production does not increase (Sutton-McDowall et al., 2010).  In this respect, at best, 
lactate production provides a crude measure of glycolytic flux. It is clear, therefore, a more 
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targeted approach is needed to directly assess follicle metabolism and the substrates it 
requires to fulfill its metabolic requirements.  
 Fluxomics employs stable isotope tracers to interrogate metabolic pathways, to 
determine the essential substrates of those pathways, and to assess the various connections 
between pathways which allow the cell to meet its energetic and biosynthetic needs 
(Berthold et al., 1994; Bequette et al., 2006).  The advantage of 13C-based fluxomics (i.e. 
13C-labelled substrates (“tracers”) and intermediates) lies in the fact that many metabolic 
pathways are interconnected, thus the 13C-labelling of downstream products of the 
metabolism of the tracer yield dynamic and quantifiable information regarding the 
operative pathways.  Patterns of incorporation of the tracer are predictable, utilizing known 
interconnections between pathways and established carbon fate maps (Mu et al., 2007, 
Metallo et al., 2009).  While these methods have been extensively employed in several 
disciplines including biomedical research and bioengineering, its potential has yet to be 
realized in the field of reproduction.  In the following work, 13C-fluxomics was employed 
to explore and interrogate metabolic pathways and their fluxes in feline follicles of different 
sizes (developmental stages) and in vivo and in vitro environments. 
 
3.2.  Rationale and Hypotheses 
 A comprehensive understanding of feline follicular metabolism is still lacking in 
reproduction science.  While strides have been made to determine the profiles of important 
metabolites, fluxes through essential metabolic pathways (e.g, glycolysis (GLYC), pentose 
phosphate pathway (PPP), Krebs cycle (TCA cycle)) and the substrates utilized in these 
pathways have yet to be determined.  While the metabolites present within a sample or cell 
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gives some clues to the function of pathways, they only provide a static, incomplete picture 
of the underlying metabolism and flux.  A more robust understanding of the ebb and flow 
of metabolites is essential not only for basic knowledge, but also for eventual improvement 
of ARTs and advancement of IVC procedures.  Metabolite fluxes through central pathways 
of carbon metabolism will provide insights into the altered metabolic demands and 
fundamental functions of follicles at different developmental stages and from different 
growth environments. 
 Two comparisons are of interest in this study, (1) the differences in carbon substrate 
flux between early and late antral follicles developed in vivo and (2) how these metabolic 
fluxes may be altered in in vitro cultured early antral follicles, as opposed to their in vivo 
derived counterparts.  In accordance with earlier studies, it was expected that the fluxes 
through glycolysis would be similar, while PPP and Krebs cycle activities would differ.   
 
3.3.  Materials and Methods  
     3.3.1.  Study Design:  Partial Block Design for Cat, Age 
 Three groups of follicles were identified for study:  early antral follicles originating 
in vivo, late antral follicles originating in vivo, and early antral follicles which underwent 
in vitro culture for 12 d.  When possible, samples for each group were obtained from a 
single cat.  Otherwise, cats of similar age (± 0.5yr) and type (house or stray cat) were paired 






     3.3.2.  Follicle Collection and Storage 
Feline ovaries were acquired as a byproduct of routine ovariohysterectomies from 
a local spay clinic, Animal Birth Control, LLC, in central Maryland.  The paired ovaries 
from sexually mature cats (defined as at least one year old) were transported to the 
University of Maryland, College Park on ice in phosphate buffered solution (PBS; Cellgro 
Mediatech, Manassas, VA).  Cortical slices were obtained from paired ovaries in warmed 
(38.5 °C) collection media (Table 3.1). Morphologically healthy, early antral (defined as 
a follicle less than 0.5 mm in diameter with a visible antrum) and late antral follicles 
(defined as a follicle greater than 2 mm in diameter with a visible antrum) were 
mechanically isolated from ovaries as previously described (Jewgenow and Goritz, 1995).  
Ten early antral follicles and singular late antral follicles from each cat were washed 
through PBS, placed into individual wells with 500 µL of tracer culture media (containing 
a 50:50 mixture of unlabeled and [U-13C]-labeled glucose; Table 3.2), and incubated for 
24 hrs in a 5% CO2 incubator at 38.5 °C.  Following incubation, the early antral follicles 
were pooled, washed through PBS, and stored at -80 °C until processing.  The spent media 
from these incubation wells were also pooled and stored at -80 °C.  The late antral follicle 
and its spent media were collected individually and stored in the same fashion.  An 
additional ten early antral follicles from each cat were encapsulated in 20 µL of 0.5% 
alginate hydrogel (Novamatrix, Sandvika, Norway), which was hardened in a salt solution 
(Table 3.3) for three minutes, washed through maintenance media (Table 3.4), and 
cultured in individual wells of a 48-well incubation plate (0.75 cm2 growth area) with 500 
µL of culture media (Table 3.5).  Incubations ran for 12 days in a 5% CO2 incubator at 
38.5 °C.  Half of the culture media was refreshed every 72 hours throughout incubation.  
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On the final day, follicles were washed through warmed PBS, transferred individually to 
500 µL of tracer culture media, and incubated for an additional 24 hrs.  Spent media was 
pooled and frozen; healthy follicles were mechanically isolated from their alginate drops 
in PBS, washed and pooled, and stored at -80 °C until processing.   
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Table 3.1:  Composition and Company Source Information for Follicle Collection 
Media. 
Follicle Collection Media:  Stored at 4°C, used at 38.5°C 
Medium 199 (TCM with Hepes) 
 
200 mL Sigma Aldrich, St. Louis, MO 
L-Glutamine 
 
0.0584 g Sigma Aldrich, St. Louis, MO 
Sodium Pyruvate:  
     100mM Stock  
 
2 mL Gibco-Life Technologies, Grand 
Island, NY 
 
Penicillin G-Streptomycin Sulfate:  
     10,000 U/mL Penicillin;   
     10,000 µg/mL Stock  
 
1 mL Invitrogen-Life Technologies, 
Grand Island, NY 
Bovine Serum Albumin 0.6 g Rockland, Inc., Gilbertsville, PA 
  
Table 3.2:  Composition and Company Source Information for Follicle Tracer 
Culture Media. 
Follicle Tracer Culture Media:  Stored at 4°C, used at 38.5°C 
Dulbecco’s Modified Eagle’s 
Medium – without Glucose, 
Glutamine, Pyruvate, and Phenol 
Red 
 
200 mL Gibco-Life Technologies, Grand 
Island, NY 
L-Glutamine  0.0584 g Sigma Aldrich, St. Louis, MO 
 
D-Glucose 0.0991 g Sigma Aldrich, St. Louis, MO 
 
Universally Labeled Carbon-13 
Glucose 
0.1024 g Cambridge Isotope 
Laboratories, Tewksbury, MA 
 
Insulin-Transferrin-Selenium:   
     25 mg/50mL Insulin-Transferrin,  
     25 ug/50mL Selenium Stock 
 
2 mL Sigma Aldrich, St. Louis, MO 
 
Penicillin G-Streptomycin Sulfate:  
     10,000 U/mL Penicillin;  
     10,000 µg/mL Stock  
 
1 mL Gibco-Life Technologies, Grand 
Island, NY 
Sodium Pyruvate:  
     100 mM Stock  
2 mL Gibco-Life Technologies, Grand 
Island, NY 
 
Bovine Serum Albumin 
 
0.6 g Rockland, Inc., Gilbertsville, PA 
Follicle Stimulating Hormone:   
     0.355 mg/mL Stock  





Table 3.3:  Composition and Company Source Information for Calcium Chloride 
Solution 
Salt Solution:  Stored and used at Room Temperature 
distilled H2O 
 
50 mL  
Calcium chloride (anhydrous) 
 
0.277 g Sigma Aldrich, St. Louis, MO 
Sodium chloride 0.410 g Sigma Aldrich, St. Louis, MO 
 
 
Table 3.4:  Composition and Company Source Information for Maintenance Media 
Maintenance Media:  Stored at 4°C, used at 38.5°C 
Dulbecco’s Modified Eagle’s 
Medium – low glucose 





0.0292 g Sigma Aldrich, St. Louis, MO 
Penicillin G-Streptomycin Sulfate:  
     10,000 U/mL Penicillin;  
     10,000 µg/mL Stock Solution 
 
0.5 mL Invitrogen-Life Technologies, 
Grand Island, NY 
Bovine Serum Albumin 0.1 g Rockland, Inc., Gilbertsville, PA 
 
 
Table 3.5:  Composition and Company Source Information for Follicle Culture 
Media. 
Follicle Culture Media:  Stored at 4°C, used at 38.5°C 
Dulbecco’s Modified Eagle’s 
Medium – low glucose 
 




0.0584 g Sigma Aldrich, St. Louis, MO 
Insulin-Transferrin-Selenium:   
     25 mg/50mL Insulin-Transferrin,  
     25 µg/50mL Selenium Stock  
 
2 mL Sigma Aldrich, St. Louis, MO 
 
Penicillin G-Streptomycin Sulfate:  
      10,000 U/mL Penicillin;  
      10,000µg/mL Stock Solution 
 
1 mL Gibco-Life Technologies, Grand 
Island, NY 
Bovine Serum Albumin 
 
0.6 g Rockland, Inc., Gilbertsville, PA 
Follicle Stimulating Hormone:   
      0.355 mg/mL Stock Solution 





     3.3.3.  Sample Processing 
All samples were slowly thawed on ice.  To each follicle sample, 1000 μL of 10% 
hydrochloric acid (HCl) in dH2O (JT Baker, Phillipsburg, NJ) was added followed by 
homogenization on ice to disrupt cell membranes.  200 µL of spent media samples were 
aliquoted into 2 mL Eppendorf Tubes and 800 µL of 0.625M HCl (JT Baker, Phillipsburg, 
NJ) was added.  All samples were placed on a vortex mixer for 15 mins, then centrifuged 
at 13,000 rpm for 10 mins to remove proteins and cellular debris.  Supernatants were 
desalted via application to an ion exchange column with 0.5 g of cation exchange resin 
(AG 50-X8, BioRad, Hercules, CA) to separate positively charged ions from the remaining 
fraction.  The initial flow through of the supernatant, as well as an additional 0.5 mL dH2O 
wash, was captured for each sample and stored at -80 °C.  The remaining fraction was 
liberated with 2 mL of 2 M ammonium hydroxide and 1 mL of distilled water, and stored 
at -80 °C.  All fractions were lyophilized (Labconco, Kansas City, MO) to dryness. 
 
       Cationic Fraction (“Amino Acid Fraction”) 
Amino acid fractions were converted to their tert-Butyldimethylsilyl derivatives.  
To fractions originating from a follicle sample, 30 µL of N-(tert-butyldimethylsilyl)-N-
methyltrifluroacetamide plus 1% t-butyldimethylchlorosilane (MTBSTFA + 
1%TBDMCS; UCT Selectra-Sil, Bristol, PA) and 30 µL dimethylformamide (DMF; 
Thermo Scientific, Waltham, MA) were added.  To fractions originating from spent media, 
60 µL of MTBSTFA + 1% TBDMCS and 60 µL DMF were added.  All samples were 
vortexed well, transferred to 0.6 mL V-Vials, and microwaved for 120 secs at 200 W.  
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Samples were transferred to glass gas chromatography vials with inserts (Agilent, Palo 
Alto, CA).   
 
       Anionic Fraction (“Glucose Fraction”) 
Glucose was converted to the di-O-isopropylidene acetate derivative (Hachey et al., 
1999).  The lyophilized glucose fraction was acidified with 1 mL of 0.38 M sulfuric acid 
in acetone and incubated at room temperature for 60 min. The solution was then neutralized 
with 2 mL of 0.44 M sodium carbonate, vortexed, and 2 mL of a saturated sodium chloride 
solution (Sigma Aldrich, St. Louis, MO) added.  Next, the O-isopropylidene derivative of 
glucose was extracted by the addition of 3 mL of ethyl acetate (JT Baker, Phillipsburg, NJ) 
followed by vortex mixing for 15 min on an orbital shaker.  Organic and aqueous phases 
were allowed to separate for 10 min, and the organic layer removed and reduced to dryness 
under a gentle stream of nitrogen (2 psi).  The O-isopropylidene derivative of glucoses was 
acetylated with 100 µL of a 50:50 mixture of ethyl acetate and acetic anhydride (JT Baker, 
Phillipsburg, NJ) and heated for 30 min at 60 °C. 
 
     3.3.4.  Gas Chromatograhy-Mass Spectrometry Analysis of Media and Follicle  
              Samples 
 
One microliter of media and two microliters of follicle sample preparations were 
injected at 10:1 and 2:1 split modes, respectively, into the gas chromatographic system 
(Agilent 6890 gas chromatography system, Palo Alto, CA) where metabolites were 
separated on a mid-polarity capillary column (Zebron ZB-50 capillary column, 
Phenomenex, Torrance, CA).  The column was subjected to the following conditions:  
initial temperature of 100 °C, ramped at 10 °C per min to temperature of 280 °C, then 
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heated at 50 °C per min to a final temperature of 300 °C, held for 3 mins (21.4 min elapsed 
run time).  Electron impact quadrupole mass spectrometry (Agilent 5973 inert EI/CI MSD 
system, Palo Alto, CA) followed, and was operated in selected ion monitoring mode to 
detect 13C-labeled carbon skeletons (Table 3.6). 
GC-MS data files were captured via Agilent’s GC-MSD ChemStation, while 
Agilent Data Analysis software was used to convert the raw data files and to determine 







Table 3.6:  Ions monitored for given metabolites in media and follicle samples 
Selected Ion Monitoring (SIM) Settings 
Amino Acids Pertinent Ions Monitored* 
Alanine [M+0]:260.2 – [M+3]: 263.2 
Aspartate [M+0]:418.4 – [M+4]: 422.4 
Glutamate [M+0]:432.4 – [M+5]: 437.4 
Glutamine [M+0]:431.4 – [M+5]: 436.4 
Glycine [M+0]:246.2 – [M+2]: 248.2 
Proline [M+0]:286.3 – [M+5]: 291.3 
Serine [M+0]:390.3 – [M+3]: 393.3 
  
Carboxylic Acid Pertinent Ions Monitored* 
Lactate [M+0]:261.2 – [M+3]: 264.2 






     3.3.5 Flux Calculations 
 Kinetic calculations were adapted from previously described reports (Bequette et 
al., 2006; Berthold et al., 1994).  In brief, actual tracer levels of glucose were obtained by 
determining the atom percent excess (APE) for the mass isotopomers of glucose (corrected 
for natural abundances; Figure 3.1).  APE was also calculated for non-essential amino 
acids (NEAAs) for use in calculations (Figure 3.2A, 3.2B), following the assumption that 
these metabolites are in isotopic equilibrium with intermediates of carbon metabolism 
(Table 3.7).  
 
The following is a summary of the calculations for Glucose carbon: 
  
          Enrichment of Acetyl CoA [M+2]Glu – 2*[M+3]Glu 
  
          Flux through PPP and PEPCK, 
          as compared to GLYC 
[M+1]Ala + [M+2]Ala 
[M+3]Ala 
 
          Ratio of flux through Pyruvate  
          Dehydrogenase versus Pyruvate  
          Carboxylase 
[M+2]Glu – 2*[M+3]Glu 
[M+3] Glu 
 
Calculations for the percent of glucose carbon contributing to the pools of: 
 
          Acetyl CoA {[M+2]Glu – 2*[M+3]Glu}/[M+6]Glc 
 
          Pyruvate (mitochondrial pool) [M+3]Ala/[M+6]Glc 
 
          Pyruvate (cytosolic pool) [M+3]Lac/[M+6]Glc 
 
























Figure 3.1:  Ion spectra of a sample of stock Tracer Culture Media with uncorrected 
APE’s calculated.  287.2, [M+0], is the unlabeled ion; 290.2, [M+3], is a triply labeled 
ion; 293.2 [M+6], is a labeled ion resulting from [U-13C]-labeled glucose fragmentation.  
The ratio of [M+6] to [M+0] gives the ratio of labeled to unlabeled glucose in the sample.  
There is 1 mole of tracer for every 1.08 moles of unlabeled glucose, as opposed to the 


















Figure 3.2:  Ion spectra of a sample containing unlabeled (A) and a mixture of 
labeled and unlabeled (B) alanine with uncorrected APE’s calculated.  The ion 
spectra of alanine, from a commercially obtained amino acid standard mixture, compared 
to the ion spectra of alanine resulting from a sample incubated with 50:50 unlabeled and 
[U-13C]-labeled glucose tracer.  260.2, [M+0], is the unlabeled ion; 263.2, [M+3], is a 








Table 3.7:  Amino & Carboxylic Acids monitored via SIM and those compounds 
with which they are in equilibrium with. 
Selected Ion Monitoring (SIM) Settings 
Amino Acids Carbon Metabolism Intermediate Approximated 
Alanine Pyruvate – mitochondrial pool 
Aspartate Oxaloacetate 
Glutamate α -Ketoglutarate 
Glutamine α -Ketoglutarate 
Glycine 3-Phosphoglycerate 
Lactate Pyruvate – cytoplasmic pool 






     3.3.6.  Statistical Analysis 
Files were analyzed with MetaboAnalyst software (online) for Partial Least Squares 
Discriminant Analysis (PLS-DA), while SAS was used to perform a mixed model analysis 
of variance (ANOVA) with Dunnett’s Correction (Xia et al., 2009; Xia and Wishart, 2011; 
Xia et al., 2012).  The following model was used: 
Yij = µ + Ti + Cj + €ij 
Yij = Response Variable (% Alanine from Glucose, % Lactate from Glucose, etc.) 
µ = Grand Mean 
Ti = Treatment Effect (Early Antral, Late Antral, Early Antral in vitro) 
Cj = Random Effects (Block:  age, type) 
€ij = Residual Error 
Significance was tested at P < 0.05 (α = 5%).  Data was analyzed with the PROC MIXED 
procedure of SAS (SAS Ins, Inc., Cary, NC) with cat age/type blocking factor.  For the 
analysis, follicle stage/type was considered a fixed effect, while the block was a random 
effect.  Least squares means were obtained for each treatment and linear effects of follicle 
stage/type on the response variables were tested by constructing orthogonal contrasts.  
Pairwise mean comparisons were done using the Dunnett’s Adjustment. 
 
3.4.  Results 
 Ion fragments containing the entire carbon skeleton of alanine, aspartate, glutamate, 
glutamine, glycine, proline, serine and lactate were monitored by GC-MS.  Ion abundances 
for each ion monitored were obtained, and corrected MIDs were calculated for each 
compound (Appendix 1). 
99 
 
 Calculations were performed to determine the contribution of glucose to the acetyl 
CoA, pyruvate (both the mitochondrial and cytosolic pools), and 3-phosphoglycerate 
carbon pools.  The relative flux through PEPCK-c and the PPP versus glycolysis were 
calculated, as well as a crude ratio of the flux through pyruvate dehydrogenase as compared 
to pyruvate carboxylase. 
 
     3.4.1.  Differences across developmental stages of follicles derived in vivo, assessed  
      via Spent Media  
As follicles increased is size (development), glucose metabolism made a greater (P 
<0.0001) contribution to mitochondrial pyruvate pool (i.e. synthesis) (Table 3.8, Figure 
3.3).  By contrast, the contribution of glucose to acetyl CoA and the cytosolic pool of 
pyruvate did not change.  In addition, throughout development, the fluxes through PEPCK-
c and PPP compared to glycolytic flux also did not change.  In addition, the ratio of 
pyruvate dehydrogenase to pyruvate carboxylase activity did not change. 
When subjected to a PLS-DA to observe clustering patterns, late antral follicles 
formed a tight cluster based on carbon flux and glucose carbon incorporation data.  This 
allowed for distinct clustering of the two groups, even with the large variation in early 
antral follicles, without major overlap between groups in a two dimensional plot (Figure 
3.4).  When three components of variation were considered, late antral follicles retained 
their tight in-group clustering, while the high variation between early antral follicles 









Table 3.8:  Calculated flux through pathways of central carbon metabolism and 
glucose carbon contributions to selected intermediate pools, as calculated from Spent 








Acetyl CoA from Glucose 0.49 ± 0.06 0.42 ± 0.06 0.5847 
Pyruvate (mitochondrial 
pool) from Glucose 
33.00 ±1.28 55.55 ±1.38 <0.0001* 
Pyruvate (cytoplasmic 
pool) from Glucose 
0.43 ±0.14 0.41 ±0.15 0.9926 
3-Phosphoglycerate from 
Glucose 
19.54 ±5.16 1.56 ±2.92 0.0367* 
PPP and PEPCK 
flux:Glycolysis Flux 




0.49 ± 0.11 0.49 ± 0.11 1.000 
1Values reported as the least squares means, plus or minus the standard error, expressed as 
moles per 100 moles of tracee for metabolites from glucose 
2P-value after Dunnett’s adjustment.  Starred values indicate a significant difference 












Figure 3.3:  [M+3] Alanine enrichment in early antral versus late antral follicles 
derived in vivo (A).  Glucose contribution to the pyruvate pool in early versus late 
antral follicles derived in vivo (B). 
 
[M+3] Alanine Enrichment
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Figure 3.4:  Two-dimensional PLS-DA of spent tracer media from early (light gray) 
and late (dark gray) antral follicles, with a 95% confidence interval indicated around 
each cluster.  The amount of variation between samples captured by each component 
is indicated in parenthesis. 
 
  























Figure 3.5:  Three-dimensional PLS-DA of spent tracer media from early (light gray) 
and late (dark gray) antral follicles. The amount of variation between samples 
captured by each component is indicated in parenthesis. 
 
  

































     3.4.2.  Differences between early antral follicles derived in vivo and those cultured  
          in vitro, assessed via Spent Media  
 No significant differences between glucose carbon contribution to intermediate 
pools or differences in fluxes through central carbon metabolism were detected between in 
vivo derived early antral follicles and those follicles recovered after in vitro incubation, 
when indirectly assessed through spent media (Table 3.9, Figure 3.6).  However, glucose 
contribution to the Acetyl CoA pool was at the cusp of being significantly lower (P = 
0.0513) in in vitro cultured early antral follicles.  These findings are supported by the 
seemingly random distribution of in vivo derived and in vitro cultured early antral follicles 
in both the two dimensional and three-dimensional PLS-DAs (Figure 3.7, 3.8).  The cluster 
formed for in vitro cultured follicles nearly encompasses the “cluster” formed for in vivo 








Table 3.9:  Calculated flux through pathways of central carbon metabolism and 
glucose carbon contributions to selected intermediate pools, as calculated from Spent 








Acetyl CoA from Glucose 0.49 ± 0.06 0.30 ± 0.06 0.0513† 
Pyruvate (mitochondrial 
pool) from Glucose 
33.00 ± 1.28 30.01 ± 1.38 0.2354 
Pyruvate (cytoplasmic 
pool) from Glucose 
0.43 ± 0.14 0.50 ± 0.15 0.9223 
3-Phosphoglycerate from 
Glucose 
19.54 ± 5.16 13.87 ± 4.05 0.5553 
PPP and PEPCK 
flux:Glycolysis Flux 




0.49 ± 0.11 0.73 ± 0.11 0.2603 
1Values reported as the least squares means, plus or minus the standard error, expressed as 
moles per 100 moles of tracee for glucose carbon contributions to metabolite pools 
2P-value after Dunnett’s adjustment.  Crossed (†) values indicate P-values at the boundary 









Figure 3.6:  [M+3] Alanine enrichment in in vivo derived early antral follicles versus 
in vitro cultured early antral follicles (A).  Glucose contribution to the pyruvate pool 
in in vivo derived early antral follicles versus in vitro cultured early antral follicles 
(B).  
[M+3] Alanine Enrichment











































Figure 3.7:  Two-dimensional PLS-DA of spent tracer media from early antral 
follicles collected directly from feline ovaries (light gray) and those subjected to in 
vitro culture (dark gray), with a 95% confidence interval indicated for each cluster. 
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Figure 3.8:  Three-dimensional PLS-DA of spent tracer media from early antral 
follicles collected directly from feline ovaries (light gray) and those subjected to in 
vitro culture (dark gray). The amount of variation between samples captured by each 
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3.4.3.  Differences between late antral follicles derived in vivo and in vitro cultured  
          early antral follicles, assessed via Spent Media  
Glucose metabolism made a greater (P <0.0001) contribution to mitochondrial 
pyruvate pool (i.e. synthesis) in late antral follicles, as opposed to in vitro cultured early 
antral follicles (Table 3.10, Figure 3.9).  By contrast, the contribution of glucose to the 
fluxes of acetyl CoA and to the cytosolic pool of pyruvate did not change.  In addition, the 
ratio of pyruvate dehydrogenase to pyruvate carboxylase activity did not change.  There 
was an observed difference between the ratios of the flux through PPP and PEPCK-c as 
compared to glycolysis (P =0.0166).   
When subjected to a PLS-DA to observe clustering patterns, late antral follicles 
formed a tight cluster based on carbon flux and glucose carbon incorporation data.  This 
allowed for fairly distinct clustering of the two groups, even with the large variation in in 
vitro cultured early antral follicles in a two dimensional plot (Figure 3.10).  When three 
components of variation were considered, clustering became more definitive.  In addition, 
late antral follicles retained their tight in-group clustering, while the high variation between 
















Table 3.10:  Calculated flux through pathways of central carbon metabolism and 
glucose carbon contributions to selected intermediate pools, as calculated from Spent 





(in vitro cultured) 
Late Antral 
(in vivo) 
Acetyl CoA from Glucose 0.31 ± 0.07 0.43 ± 0.07 0.2647 
Pyruvate (mitochondrial 
pool) from Glucose 
30.63 ± 1.26 56.07 ±1.26 <0.0001* 
Pyruvate (cytoplasmic 
pool) from Glucose 
0.50 ±0.12 0.43 ±0.12 0.6666 
3-Phosphoglycerate from 
Glucose 
12.92 ± 4.47 2.76 ±3.01 0.1324 
PPP and PEPCK 
flux:Glycolysis Flux 




0.73 ± 0.15 0.48 ± 0.15 0.2794 
1Values reported as the least squares means, plus or minus the standard error, expressed as 
moles per 100 moles of tracee for metabolites from glucose 
2P-value after Dunnett’s adjustment.  Starred values indicate a significant difference 











Figure 3.9:  [M+3] Alanine enrichment in in vitro cultured early antral follicles versus 
in vivo derived late antral follicles (A).  Glucose contribution to the pyruvate pool in 




























































Figure 3.10:  Two-dimensional PLS-DA of spent tracer media from late antral follicles 
collected directly from feline ovaries (dark gray) and in vitro cultured early antral 
follicles (dark gray), with a 95% confidence interval indicated for each cluster. The 












Figure 3.11:  Three-dimensional PLS-DA of spent tracer media from late antral 
follicles collected directly from feline ovaries (dark gray) and in vitro cultured early 
antral follicles (dark gray). The amount of variation between samples captured by 





     3.4.4.  Differences among follicle stages and environmental conditions, through  
direct assessment of follicles 
 Significant differences were not detected between in vivo derived early antral 
follicles and late antral follicles or between in vivo derived early antral follicles and in vitro 
cultured early antral follicles when direct analysis of follicles was completed (Tables 3.11, 
3.12).   However, there was a significantly higher contribution of glucose carbon to the 
mitochondrial pool of pyruvate (P =0.0332) and a significantly lower contribution of 
glucose carbon to the acetyl CoA pool (P=0.0128) in late antral follicles derived in vivo as 
compared to in vitro cultured early antral follicles (Table 3.13).  Upon analysis with PLS-
DA, no distinct clustering patters were able to be observed in either two-dimensional or 
three-dimensional analysis for the comparisons between in vivo early antral follicles and 
late antral follicles or between in vivo derived early antral follicles and in vitro cultured 
early antral follicles; rather, it appears that individuals from all experimental groups were 
dispersed randomly (Figures 3.12, 3.13, 3.14, 3.15).  While there is overlap between in 
vitro cultured early antral follicles and in vivo derived late antral follicles in two-












Table 3.11:  Calculated flux through pathways of central carbon metabolism and 
glucose carbon contributions to selected intermediate pools, as calculated from 
Follicles (n=9 per group)1 
Flux/Intermediate 
Follicle Stage 
P Early Antral (in vivo) Late Antral (in vivo) 
Acetyl CoA from 
Glucose 




22.41 ± 5.3 37.99 ± 2.98 0.0726 
Pyruvate (cytoplasmic 
pool) from Glucose 
0.50 ± 0.29 0.89 ± 0.33 0.5855 
PPP and PEPCK 
flux:Glycolysis Flux 




0.53 ± 0.23 0.91 ± 0.13 0.2940 
1Values reported as the least squares means, plus or minus the standard error.  














Figure 3.12:  Two-dimensional PLS-DA of early (light gray) and late (dark gray) 
antral follicles after incubation in tracer media, with a 95% confidence interval 
indicated around each cluster.  The amount of variation between samples captured 


























Figure 3.13:  Three-dimensional PLS-DA of early (light gray) and late (dark gray) 
antral follicles after incubation in tracer media.  The amount of variation between 







































Table 3.12:  Calculated flux through pathways of central carbon metabolism and 
glucose carbon contributions to selected intermediate pools, as calculated from 








Acetyl CoA from Glucose 2.04 ± 0.67 3.98 ± 0.60 0.0892 
Pyruvate (mitochondrial 
pool) from Glucose 
22.41 ± 5.3 26.23 ± 5.33 0.8175 
Pyruvate (cytoplasmic 
pool) from Glucose 
0.50 ± 0.29 1.16 ± 0.29 0.2131 
PPP and PEPCK 
flux:Glycolysis Flux 




0.53 ± 0.23 0.83 ± 0.20 0.4807 
1Values reported as the least squares means, plus or minus the standard error.  










Figure 3.14:  Two-dimensional PLS-DA of early antral follicles derived in vivo (light 
gray) and those subjected to IVC (dark gray) after incubation with tracer media, 
with a 95% confidence interval indicated around each cluster.  The amount of 
variation between samples captured by each component is indicated in parenthesis. 
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Figure 3.15:  Three- dimensional PLS-DA of early antral follicles derived in vivo 
(light gray) and those subjected to IVC (dark gray) after incubation with tracer 
media.  The amount of variation between samples captured by each component is 
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Table 3.13:  Calculated flux through pathways of central carbon metabolism and 
glucose carbon contributions to selected intermediate pools, as calculated from 




Early Antral  
(in vitro cultured) 
Late Antral  
(in vivo) 
Acetyl CoA from 
Glucose 




27.95 ± 2.36 37.99 ± 1.26 0.0332* 
Pyruvate (cytoplasmic 
pool) from Glucose 
1.35 ± 0.21 0.90 ± 0.21 0.1708 
PPP and PEPCK 
flux:Glycolysis Flux 




0.81 ± 0.19 0.91 ± 0.12 0.6836 
1Values reported as the least squares means, plus or minus the standard error.  
Contributions of glucose carbon to metabolite pools is expressed in moles per 100 moles 
of tracee 
2P-value after Dunnett’s adjustment.  Starred (*) values indicate a significant difference 








Figure 3.16:  Two-dimensional PLS-DA of in vitro cultured (light gray) and in vivo 
derived late antral follicles (dark gray) after incubation with tracer media, with a 
95% confidence interval indicated around each cluster.  The amount of variation 











Figure 3.17:  Three-dimensional PLS-DA of in vitro cultured (light gray) and in vivo 
derived late antral follicles (dark gray) after incubation with tracer media.  The 








3.5.  Discussion 
 Most previous studies regarding follicle metabolism have focused on static 
measurements of metabolite concentrations, whether directly from follicular fluid or from 
the entire follicle, or on metabolite disappearance and appearance in spent media.  Even in 
the most recent metabolomics studies of follicular fluid, only a limited picture of 
metabolism can be achieved – a single snapshot of the follicle in time is captured, without 
regards to the ebb and flow of metabolites through physiologic pathways.  Understanding 
the metabolism of follicles will enable future research to innovate in vitro culture media to 
better accommodate the needs of follicles.  As previous research has shown, even simply 
altering glucose concentrations in culture media can have catastrophic results on the 
developmental capacity of female gametes (Sutton et al., 2010).  To address these 
shortcomings, the objective of the current study was to utilize stable isotope tracers to track 
the flux of glucose carbon through follicles of different developmental stages and 
developmental environments. 
 In order to address this objective, a follicle culture media was formulated with 50% 
unlabeled glucose and 50% [U-13C6] glucose tracer.  After twenty-four hours of individual 
incubation in the media, consistent labeling of follicles can be achieved (as determined 
previously), while minimizing the effect on the follicles.  While the flux of metabolites 
through pathways in follicles has not been directly analyzed previously, flux in oocytes has 
been minimally explored.  For those oocytes which undergo in vitro maturation (as COCs), 
glycolysis is highly active in granulosa cells and pyruvate and lactate, the resulting 
metabolites, are metabolized through the Krebs cycle, followed by oxidative 
phosphorylation (Seeves and Gardner, 1999).  Sutton et al. (2010), asserted that pentose 
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phosphate pathway activity in the cumulus granulosa cells and oocyte are low, although 
oocytes have a higher potential for pentose phosphate pathway activity.  Activity of 
glucose-6-phosphate dehydrogenase, the first step of carbon allotment into the pentose 
phosphate cycle, has been qualitatively assessed in oocytes, pre-maturation, and low 
activity linked to higher quality oocytes (Mohammadi-Sangcheshmeh et al., 2011).   
 Four main pathways of glucose metabolism in cumulus-oocyte complexes have 
been proposed:  the polyol pathway, hexosamine pathway, the pentose phosphate pathway 
and glycolysis (Sutton et al., 2010).  The pentose phosphate pathway and glycolysis in 
whole follicles were quantitatively evaluated with this research. 
 
     3.5.1.  Non-Invasive Analysis of Follicle Metabolism 
       3.5.1.1.  Glycolysis 
 When moles of [M+n] Glycine were calculated and normalized to 100 moles of 
[M+0] tracee, there was a significant difference (P = 0.0014) detected between the labeling 
of [M+2] Glycine in early and late antral follicles derived in vivo, as well as between in 
vitro cultured early antral follicles and in vivo derived late antral follicles (P =0.0069) 
(Table 3.14).  The [M+2] labeling pattern is only observed when glucose carbon is 
metabolized strictly through glycolysis to 3-phosphoglycerate, then to serine, and then to 
glycine, indicating that flux through glycolysis significantly increases as follicles develop 
from the early to late antral stage.  There was no significant difference between early antral 




Table 3.14: (A) Moles of tracer per 100 moles of tracee, as detected in early and late 
antral follicles (n=9), (B) Moles of tracer per 100 moles of tracee, as detected in early 
antral follicles derived in vivo and cultured in vitro (n=9), (C) Moles of tracer per 
100 moles of tracee, as detected in late antral follicles and in vitro cultured early 












[M+2] Glycine 0.33 ± 0.01 0.66 ± 0.07 0.0014* 
[M+3] Alanine 30.19 ± 1.60 51.18 ± 1.48 < 0.0001* 
[M+3] Lactate 0.43 ± 0.18 0.40 ± 0.04 0.8292 
[M+2] Glutamate 2.37 ± 0.49 2.18 ± 0.25 0.4989 
[M+3] Glutamate 0.96 ± 0.07 0.90 ± 0.11 0.6173 
[M+3] Serine 0.17 ± 0.02 0.75 ± 0.09 0.0003* 













[M+2] Glycine 0.34 ± 0.01 0.38 ± 0.01 0.0686 
[M+3] Alanine 31.44 ± 1.33 28.65 ± 1.07 0.0880 
[M+3] Lactate 0.42 ± 0.18 0.47 ± 0.13 0.8268 
[M+2] Glutamate 2.40 ± 0.16 1.04 ± 0.14 < 0.0001* 
[M+3] Glutamate 0.97 ± 0.07 0.38 ± 0.04 <0.0001* 
[M+3] Serine 0.17 ± 0.02 0.13 ± 0.01 0.2476 














(in vitro cultured) 
Late Antral 
(in vivo) 
[M+2] Glycine 0.38 ± 0.06 0.68 ± 0.06 0.0069* 
[M+3] Alanine 28.40 ± 1.17 52.00 ± 1.17 <0.0001* 
[M+3] Lactate 0.47 ± 0.11 0.40 ± 0.11 0.6633 
[M+2] Glutamate 1.07 ± 0.23 2.29 ± 0.23 0.0071* 
[M+3] Glutamate 0.39 ± 0.11 0.95 ± 0.11 0.0071* 
[M+3] Serine 0.17 ± 0.02 0.13 ± 0.01 0.0005* 
[M+2] Proline 0.73 ± 1.5 2.00 ± 1.50 0.5701 
1Values reported as the mean, plus or minus the standard error, expressed as moles per 100 
moles of tracee 
2 P-value after pairwise t-test.  Starred (*) values indicate a significant difference between 




Much as with [M+2] glycine, [M+3] alanine is only produced when [U-13C6] 
glucose is taken up by the follicle and metabolized directly through glycolysis to pyruvate.  
51.18 (±1.48) moles of [M+3] alanine were present per 100 moles of tracee in late antral 
follicles, while only 30.19 (±1.60) moles of [M+3] alanine were present per 100 moles of 
tracee in early antral follicles.  These findings were reflected in the comparison between in 
vivo derived late antral follicles and in vitro cultured early antral follicles.  Again, these 
findings reflect a significant increase (P <0.0001) in [M+3] alanine, therefore glycolytic 
activity and glucose contribution to the pyruvate pool, in late antral follicles over early 
antral follicles.  Conversely, no significant difference was detected between in vivo derived 
early antral and in vitro cultured early antral follicles (Table 3.14).   
 There were no significant changes in [M+3] lactate abundance across 
developmental stages or environmental conditions (Table 3.14).  This finding is surprising 
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as lactate is generally accepted to be in isotopic equilibrium with the pyruvate pool; 
therefore, similar results in labeling patterns between lactate and alanine would be 
expected.  It appears that there is compartmentalization of the pyruvate pool (mitochondrial 
vs. cytosolic) in follicles.  If that is the case, severe dilution of the tracer could occur 
independently in the lactate pool given an influx of alternative endogenous carbon sources 
-- for example, via metabolism of glycerol to lactate.  In bovine follicles, triglycerides are 
at highest concentrations in small follicles and decreased concentrations in large, late antral 
follicles (Leroy et al., 2004b).  If triglycerides are metabolized, glycerol and fatty acids are 
released, and glycerol can be converted to lactate.  It would follow that triglyceride 
concentrations would be depleted in large follicles as more lactate is being produced, which 
is consistent with current and previous results.   
 While serine labeling was measured, erratic results were obtained.  Given the 
presence of serine in the culture medium, it would be expected that severe dilution of the 
tracer would occur.  Additionally, as tracer ([M+3] serine) abundances decrease, the 
accuracy with which they can be determined is diminished.  After correction for natural 
labeling, error in the serine labeling patterns is compounded, giving highly negative, as 
well as impossibly high results for tracer abundances.  While additional testing is 
warranted, these results suggest that serine does not serve as a reliable indicator of the 3-
phosphoglycerate pool or for glycolytic activity. 
As discussed previously, pyruvate is in isotopic equilibrium with alanine and 
lactate; therefore, the contributions of glucose carbon to the pyruvate carbon pool can be 
estimated by correcting the [M+3] enrichments of alanine and lactate for the abundance of 
[M+6] glucose in the media.  There are no significant differences in the contributions of 
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glucose carbon to the cytosolic pyruvate pool (approximated by lactate) in any of the 
groups.  Glucose carbon comprised a higher proportion of the mitochondrial pyruvate pool 
in late antral versus early antral follicles, in vivo derived and in vitro cultured.  This could 
reflect an increased glycolytic flux in late antral follicles, or a decrease in contributions of 
alternative carbon sources (e.g., amino acid catabolism). 
 
3.5.1.2.  Urea Cycle 
 No significant differences in proline labeling were detected among groups, either 
between follicles of different developmental stages or between environmental conditions 
(Table 3.14).  Slightly negative values for [M+3] proline are likely a combined result of 
low [M+3] abundances as well as imperfect background fitting, which causes error in the 
natural isotope corrections.  Interestingly however, [M+2] proline labeling tends to be 
lower than [M+2] glutamate abundance in early and late antral follicles derived in vivo 
([M+2] proline being about 83% of the [M+2] glutamate) (Figure 3.18).  Proline is 
typically in isotopic equilibrium with glutamate; however, tracer dilution in proline would 
occur if the cells had an active urea cycle.  During this process, arginine is converted to 
ornithine via arginase, which results in the release of urea, then ornithine can form proline.  
Urea was annotated in metabolomic analysis of feline follicles but was inconsistent.  
However, urea has been detected in the follicles of several species in previous studies.  In 
bovine follicles, urea is higher in small and mid-size follicles (early antral stage) than in 
late antral stage follicles.  This is indicative of a highly functioning urea cycle (arginase 
activity) in early antral follicles, with lower activity in late antral follicles, which mirrors 
tracer dilution results.  Results are inconclusive, however, feline follicles should be 
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evaluated for a functioning urea cycle.  It would not be surprising to find that feline follicles 
do in fact exhibit high arginase activity, given the uncontrolled, high functionality of the 
urea cycle in adult felids (Morris et al., 2002). 
 
 
Figure 3.18:  [M+2] glutamine and proline enrichments for early antral and late 
antral follicles derived in vivo.  [M+2] proline enrichment consistently tends to be about 
83% of [M+2] glutamate enrichment. 
  
 
3.5.1.3.  TCA Cycle, PPP, and PEPCK-c 
 [M+2] Glutamate can result from one of two metabolic courses.  It can result from 
the entrance of [M+2] Acetyl CoA into the TCA Cycle, in which [M+2] α-Ketoglutarate is 
produced in the first turn (which can then be metabolized to [M+2] glutamate).  It can also 
result from pyruvate carboxylase activity, converting [M+3] pyruvate to [M+3] 
oxaloacetate.  Oxaloacetate exhibits two positional isotopomers due to its equilibrium with 
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malate.  If [M+3]C1-C3 oxaloacetate forms α-ketoglutarate, [M+2] α-ketoglutarate will result 
on the first turn of the cycle; however, if [M+3]C2-C4 oxaloacetate proceeds, it will form 
[M+3] α-ketoglutarate on the first turn of the cycle and [M+2] α-ketoglutarate on the 
second turn. This pathway, which results in [M+3] α-ketoglutarate formation, is the only 
pathway which will result in [M+3] glutamate production.   No significant differences in 
[M+2] or [M+3] glutamate abundances are observed in in vivo derived early and late antral 
follicles.  However, altering the follicle environment results in a decrease in both [M+2] 
and [M+3] glutamate in in vitro cultured early antral follicles as compared to in vivo 
derived early and late antral follicles (Table 3.14). This suggests that there is decreased 
entrance of glucose carbon into the TCA cycle in in vitro cultured early antral follicles.  
Metabolomics data suggests that TCA activity remains constant in feline follicles.  It 
follows that alternative anapleurotic carbon sources are utilized in these follicles, possibly 
including fatty acid oxidation. 
 Evaluation of the abundances of alanine isotopomers can elucidate the main 
pathways of glucose carbon metabolism.  Again, [M+3] alanine can only result when [U-
13C6] labeled glucose is metabolized through glycolysis to pyruvate.  [M+1] and [M+2] 
alanine result primarily from activity of the pentose phosphate pathway, where a single 
glucose carbon is lost as carbon dioxide when ribulose-5-phosphate is formed, and carbon 
rearrangements occur.  These two isotopomers can also result from phosphoenolpyruvate 
(PEP) synthesis via PEP carboxykinase (cytosolic) (PEPCK-c), which can then be 
converted to pyruvate.  Therefore, a ratio of [M+1] and [M+2] to [M+3] alanine can give 
a crude estimate of PPP/PEPCK-c to glycolytic activity.  This ratio, 0.09, 0.08, and 0.10, 
for early antral, late antral, and in vitro cultured early antral follicles respectively, did not 
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change between in vivo derived early and late antral follicles or between in vivo derived 
and in vitro cultured early antral follicles; however, there was a change detected between 
late antral follicles and in vitro cultured early antral follicles.  For feline follicles, there 
does not appear to be a shift in the comparative glycolytic activity to pentose phosphate 
activity between developmental stages in the cat, or early antral follicles in different 
environmental conditions.  Instead, in accordance with previous reports, there is a 
consistently higher glycolytic flux than PPP flux.  However, given the heightened 
glycolytic activity in late antral follicles, a matched increase in PPP and PEPCK-c activity 
would be expected to maintain the ratio.  For early and late antral follicles, as compared to 
preantral follicles, the increase in follicle diameter is due largely to an increase in the 
amount of follicular fluid produced, rather than a large increase in cell proliferation.  
Without increased cell proliferation, activity of the PPP would not be expected to increase, 
as its two main functions are to produce reducing equivalents and pentoses for nucleic 
acids.  However, during this time course, oocytes are growing and accumulating mRNAs 
which will be utilized by early embryos until embryonic genome activation, which could 
account for the higher PPP flux observed in follicles.  Conversely, when late antral follicles 
are compared to in vitro cultured early antral, there is a marked difference between the flux 
through the PPP and PEPCK-c as compared to glycolysis.  It appears that in in vitro 
cultured early antral follicles there is a disproportionate shift in glucose flux through the 
PPP and PEPCK-c.  The case has been made that in embryos, those with the quietest 
metabolisms are the most viable to continue growth and development (Leese et al., 2008).  
It may be possible that the same is true in follicles, and that these in vitro cultured early 
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antral follicles (which achieved minimal growth in culture, see Chapter 2), are not as able 
to continue development due to their overactive metabolisms (PPP and PEPCK-c fluxes). 
Previous reports by Berthold et al. (1994), have utilized the abundances of [M+3] 
aspartate and [M+2] and [M+3] glutamate to calculate the enrichment of acetyl CoA.  
Aspartate was not accurately detected for the media assessed, most likely because of its 
low abundance in samples or low derivatization efficiency; however, a rough estimate for 
[M+3] aspartate can be calculated from [M+3] glutamate.  Given that [M+3] glutamate can 
only derive from oxaloacetate labeled at carbons 2, 3, and 4, and that oxaloacetate’s two 
positional isotopomers are in equilibrium, [M+3] aspartate is at least two times higher than 
[M+3] glutamate.  If oxaloacetate is at perfect equilibrium, [M+3] glutamate is half of 
[M+3] aspartate.  Using this information and the equation established by Berthold et al., it 
was determined that acetyl CoA enrichment is similar in in vivo derived early and late 
antral follicles, while there appears to be a slight decrease in enrichment in in vitro cultured 
early antral follicles as compared to their in vivo derived counterparts.  The decrease in 
glucose contribution to the acetyl CoA pool would most likely due to an increased 
contribution of acetyl CoA from fatty acid oxidation in these follicles.  More interesting to 
note is the large difference in glucose contribution to the pyruvate pool as opposed to the 
acetyl CoA pool.  Further work is needed to determine what contributions the pyruvate 
pool is making to the metabolisms in feline follicles, as it appears that very little of pyruvate 
is converted to acetyl CoA for entrance to the TCA cycle. 
A visual summary of the metabolic differences between in vivo derived early antral 
follicles, in vivo derived late antral follicles, and in vitro cultured early antral follicles is 








Figure 3.12:  Comparison of metabolism through the central carbon pathway in in 
vivo derived early antral follicles as compared to in vivo derived late antral follicles.  
Gray arrows () indicate a flux (e.g., flux through glycolysis, flux to Proline), plus signs 
(+) indicate an increase in late antral follicles over in vivo derived early antral follicles, and 
an equal sign (=) indicates equivalence.  There is an increase in glycolytic flux, as well as 
proportional increase in flux through PPP and PEPCK-c in late antral follicles.  
Enrichments of acetyl CoA ([M+2]) and α-ketoglutarate ([M+2] and [M+3] glutamate) are 
equivalent.  There is an additional, equivalent contribution to the proline pool, diluting the 

















Figure 3.13:  Comparison of metabolism through the central carbon pathway in in 
vivo derived early antral follicles as compared to in vitro cultured early antral follicles.  
Gray arrows () indicate a flux (e.g., flux through glycolysis), plus signs (+) indicate an 
increase in in vitro cultured early antral follicles over in vivo derived early antral follicles, 
minus signs (-) indicate a decrease in in vitro cultured early antral follicles as compared to 
in vivo derived early antral follicles, and an equal sign (=) indicates equivalence.  There is 
an equivalent glycolytic flux, as well as a maintained ratio of PPP and PEPCK-c flux to 
glycolysis in in vitro cultured early antral follicles.  Enrichments of acetyl CoA ([M+2]) 
and α-ketoglutarate ([M+2] and [M+3] glutamate) are decreased in in vitro cultured early 













Figure 3.14:  Comparison of metabolism through the central carbon pathway in in 
vivo derived late antral follicles as compared to in vitro cultured early antral follicles.  
Gray arrows () indicate a flux (e.g., flux through glycolysis), plus signs (+) indicate an 
increase in in vitro cultured early antral follicles over in vivo derived late antral follicles, 
minus signs (-) indicate a decrease in in vitro cultured early antral follicles over in vivo 
derived late antral follicles, and an equal sign (=) indicates equivalence.  There is a decrease 
in glycolytic flux, but an increase in the ratio of PPP and PEPCK-c flux to glycolysis in in 
vitro cultured early antral follicles as compared to late antral follicles.  Enrichment of acetyl 
CoA ([M+2]) is equivalent between groups, while α-ketoglutarate ([M+2] and [M+3] 
glutamate) is decreased in in vitro cultured early antral follicles, indicating an increase in 





       3.5.1.4.  Partial Least Squares Analysis based on results from spent media 
 Tight clustering of late antral follicles derived in vivo, discriminant from early 
antral follicles derived in vivo and from in vitro cultured early antral follicles, in both 2D 
and 3D PLS-DA suggests that the variability in the metabolism in late antral follicles, with 
regards to glucose metabolism, are low.  This could provide a good model to assess follicle 
class via metabolic evaluation.  Assessment of atretic follicles, as opposed to healthy 
follicles, using these evaluation measures could provide insight into markers for good 
versus poor quality follicles and oocytes.  Indistinct clustering of early antral follicles 
derived directly from the ovary and those subjected to in vitro culture suggest that there is 
large variation in the metabolism of these two groups, and that their metabolisms do not 
greatly differ from one another.  There appears to be a decreased ability of early antral 
follicles to progress to the late antral stage when cultured in vitro (as suggested by the 
minimal growth observed in in vitro cultured early antral follicles, observed during the 
metabolomics study), it does not appear to be due to a fundamental difference in glucose 
carbon metabolism of the two groups of early antral follicles, but rather an inability of the 




     3.5.2.  Direct Analysis of Follicle Metabolism 
 Direct analysis of feline follicles did not offer many significant differences in flux 
and glucose carbon contributions to intermediate pools.  Glucose contribution to the 
pyruvate pool (as assessed via alanine labeling) was higher in late antral follicles as 
compared to in vitro cultured early antral follicles.  This result is in line with the results 
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obtained from analysis of the spent media.  The difference in glucose contributions to the 
pyruvate pool may have been detected, while other differences were not, given that alanine 
enrichment was the highest among those amino acids monitored (potentially allowing it to 
be accurately detected even with the smaller sample size).  Conversely, glucose’s 
contribution to the acetyl CoA pool was lower in late antral follicles as compared to in vitro 
cultured early antral follicles, which was not reflected in the analysis of spent media.  While 
it would be expected that similar enrichment patterns would be observed in spent media 
and their corresponding follicle samples, and that similar differences between groups 
would be observed during direct and indirect assessment, it appears that this is not the case.  
Due to very small amounts of available material for processing, it is possible that 
abundances were too near the threshold of detection for the GC-MS platform for accurate 
quantification of ions.  Any deviations from the true abundance of ions would have been 
compounded through natural isotope abundance correction, and the subsequent 
calculations.  It is possible that collection of higher numbers of follicles, especially at the 
early antral stage, may be required for analysis with this platform.  However, because 
analysis of spent media provides a more clinically valuable avenue for analysis, that is, the 
media can be tested and the follicles and oocytes are left intact for culture and use in ARTs, 
further research should be carried out to determine if fluxes determined through analysis 









Chapter 4:  Concluding Remarks and Future Directions 
 
 
 Feline follicles of different developmental stages and environmental conditions 
were considered in this study.  Fundamental differences in metabolite profiles and carbon 
metabolism were observed among early antral and late antral follicles, suggesting that 
follicles which successfully progress through folliculogenesis undergo metabolic shifts in 
order to do so.  Furthermore, while it seems that early antral follicles cultured in vitro have 
a lower capacity than those derived in vivo to grow to the late antral stage (suggested by 
the minimal growth of in vitro cultured early antral follicles, as described in Chapter 2) the 
difference is not due to a fundamental metabolic difference in the early antral follicles 
themselves, but rather an inability to shift to the metabolism which marks late antral 
follicles.  Further research is needed in order to truly understand the metabolism of these 
dynamic structures.  Isolation of oocytes from follicular cells (granulosa and theca), as well 
as isolation of follicular fluid from these two cellular pools will provide a more specific, 
targeted view of metabolism.  As of yet, metabolite profiles are confounded because of the 
numerous cell types present in samples.   
The metabolomics and fluxomics procedures refined for this study can easily be 
applied to gamete and embryo evaluation, providing essential metabolic information which 
could be used to define viable follicles, gametes, and embryos for model species.  The 
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increased understanding of metabolism in these structures will also allow for refinement of 
present ARTs (e.g., culture media formulation), and potentially make possible the culture 
of preantral follicles to the late antral stage.  Further research regarding preantral follicle 
metabolism using metabolomic and fluxomic technologies, followed by development of 
effective IVC methods can unlock access to follicles and oocytes which are currently 
unavailable (Gupta and Nandi, 2012).  Effective culture methods for most species are only 
available for antral follicles, which severely limits quantities available for use, and 
effectively wastes thousands of preantral follicles and their oocytes which are ultimately 
lost to atresia.  Once culture methods for preantral follicles are developed, thousands of 
additional oocytes per animal will be available for embryo production (Gutierrez et al., 
2000).  This outcome has already been realized and employed with limited success in mice 
(Hasegawa et al., 2004 and 2006). 
 While there are many facets to breeding exotic species which need to be addressed, 
including reproductive physiology, cyclicity of females, and behavior, there is a basic need 
for development of efficient ART’s, which is only possible with better understandings of 
gamete, follicle, and embryo metabolism.  This is an imperative to the effort to perpetuate 
genes, to maintain and increase genetic variability, and to allow for gamete rescue.  Even 
with comprehensive conservation plans, genetic diversity is limited because of the limited 
number of individuals.  When even a single individual is lost because of injury, disease, or 
natural death, ARTs provide an opportunity for gamete rescue.  Post-mortem collection of 
follicles from African Black Rhinoceros have been carried out, and showed limited success 
in producing cleavage stage embryos.  With further assessment of follicle and oocyte 
141 
 
metabolism, it may be possible to refine culture techniques to increase efficiency (Stoops 
et al., 2011).   
Finally, ART’s for livestock and exotic species need to be improved to allow for 
selection of the most viable oocytes and embryos to decrease the need for multiple embryo 
transfer.  This will improve safety for recipient animals and decrease the wastage of 





Appendix 1:  Mass Isotopomer Distributions for monitored amino acids, standardized as moles [M+n] per 100 moles of [M+0], 
reported as an average ± standard error.  Tables A-C report values for the spent tracer media for early antral follicles derived 
in vivo and cultured in vitro and late antral follicles derived in vivo.  Tables D-E report values for follicular samples. 
 
A 
Glycine Alanine Lactate 
[M+1] [M+2] [M+1] [M+2] [M+3] [M+1] [M+2] [M+3] 
Early Antral 
Follicles 
 (in vivo) 
2.33±0.21 0.34±0.01 0.81±0.07 1.92±0.11 30.56±1.48 0.06±0.04 -0.25±0.01 0.40±0.16 
Late Antral 
Follicles 
 (in vivo) 
1.68±0.30 0.66±0.07 1.24±0.10 2.91±0.11 51.18±1.48 0.03±0.02 -0.27±0.07 0.40±0.04 
Early Antral 
Follicles 
 (in vitro) 










Serine  Glutamate 
[M+1] [M+2] [M+3]  [M+1] [M+2] [M+3] [M+4] [M+5] 
Early Antral 
Follicles 
 (in vivo) 
0.12±0.01 0.00±0.01 0.16±0.02  0.72±0.06 2.37±0.15 0.96±0.07 0.02±0.01 -0.39±0.02 
Late Antral 
Follicles 
 (in vivo) 
0.86±0.16 0.43±0.10 0.75±0.09  0.71±0.10 2.18±0.26 0.90±0.11 0.04±0.01 0.02±0.00 
Early Antral 
Follicles 
 (in vitro) 






[M+1] [M+2] [M+3] [M+4] [M+5] 
Early Antral 
Follicles 
 (in vivo) 
1.30±0.41 1.99±0.65 -2.32±0.25 -0.04±0.05 0.15±0.01 
Late Antral 
Follicles 
 (in vivo) 
0.71±0.68 1.82±0.50 -1.09±0.40 -0.29±0.06 0.09±0.02 
Early Antral 
Follicles 
 (in vitro) 





Glycine Alanine Lactate 
[M+1] [M+2] [M+1] [M+2] [M+3] [M+1] [M+2] [M+3] 
Early Antral 
Follicles 
 (in vivo) 
49.10±26.63 2.15±0.48 0.29±0.31 0.73±0.51 22.80±2.48 -0.33±0.29 -0.59±0.54 0.47±0.25 
Late Antral 
Follicles 
 (in vivo) 
43.98±10.68 1.88±0.19 0.90±0.10 1.94±0.18 35.30±2.91 0.01±0.04 -0.24±0.04 0.81±0.16 
Early Antral 
Follicles 
 (in vitro) 





Glutamate  Proline 
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